Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
APOA2,Apolipoprotein A-II,Lifestyle factors,X1050.Time spend outdoors in summer,47443,0.0217324233263037,0.0292672325997711,-0.0356313525692478,0.0790961992218551,0.457762905014781
APOA2,Apolipoprotein A-II,Lifestyle factors,X1060.Time spent outdoors in winter,45582,0.00146323163163643,0.0324317271780509,-0.0621029536373434,0.0650294169006162,0.964014369986167
APOA2,Apolipoprotein A-II,Physical activities,X1070.Time spent watching television (TV),48474,0.0592173393183679,0.0298709954963087,0.000670188145602817,0.117764490491133,0.0474446272361449
APOA2,Apolipoprotein A-II,Physical activities,X1080.Time spent using computer,45575,-0.0903640619342963,0.028884086645629,-0.146976871759729,-0.0337512521088635,0.00176005041885535
APOA2,Apolipoprotein A-II,Physical activities,X1090.Time spent driving,41969,-0.10818104397395,0.0331897274295869,-0.173232909735941,-0.0431291782119601,0.00111911129175419
APOA2,Apolipoprotein A-II,Lifestyle factors,X1160.Sleep duration,49168,-0.0116816974138866,0.026129534698642,-0.0628955854232249,0.0395321905954517,0.654830296896808
APOA2,Apolipoprotein A-II,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34784,0.0123245390696422,0.021436700543956,-0.0296913939965116,0.054340472135796,0.56536377051871
APOA2,Apolipoprotein A-II,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34784,0.00826881547681645,0.0205310979275863,-0.0319721364612526,0.0485097674148855,0.687150565931108
APOA2,Apolipoprotein A-II,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34784,0.0597431634214687,0.022537917308552,0.0155688454967067,0.103917481346231,0.00805314175043225
APOA2,Apolipoprotein A-II,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34784,0.053001541699841,0.0228117120018862,0.00829058617614415,0.0977124972235379,0.0201914586506117
APOA2,Apolipoprotein A-II,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34784,0.0334525159366978,0.0228200920988855,-0.0112748645771178,0.0781798964505134,0.142725295510762
APOA2,Apolipoprotein A-II,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34784,0.0783366705500297,0.0585780176347162,-0.0364762440140141,0.193149585114073,0.181177540474107
APOA2,Apolipoprotein A-II,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34784,0.11795462164688,0.0589812737515959,0.00235132509375212,0.233557918200008,0.0455630774694119
APOA2,Apolipoprotein A-II,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34784,0.0190748000188768,0.0398416095077047,-0.0590147546162244,0.0971643546539781,0.632123975383899
APOA2,Apolipoprotein A-II,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34784,0.0309662446723277,0.02843143177159,-0.0247593615999888,0.0866918509446442,0.276132357071563
APOA2,Apolipoprotein A-II,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34784,-6.72214438705943e-05,0.0185123494463349,-0.0363514263586869,0.0362169834709457,0.997102883356558
APOA2,Apolipoprotein A-II,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34784,0.0358526861892848,0.0278947953940916,-0.0188211127831348,0.0905264851617044,0.198746907505626
APOA2,Apolipoprotein A-II,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34784,0.00920178868152407,0.0149828128150131,-0.0201645244359017,0.0385681017989498,0.539137049631559
APOA2,Apolipoprotein A-II,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34784,0.00702494092424187,0.0193260819831335,-0.0308541797626999,0.0449040616111836,0.716248631797131
APOA2,Apolipoprotein A-II,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34784,0.0538793626858211,0.0279272046847333,-0.000857958496256181,0.108616683867898,0.053746822262644
APOA2,Apolipoprotein A-II,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34784,0.0215368192096124,0.0261645051597635,-0.0297456109035241,0.0728192493227489,0.410468529682696
APOA2,Apolipoprotein A-II,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34784,0.0479278671533416,0.0406515286938459,-0.0317491290865964,0.12760486339328,0.238451148129203
APOA2,Apolipoprotein A-II,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34784,0.0471475163149825,0.0386790626623421,-0.0286634465032081,0.122958479133173,0.222917815593204
APOA2,Apolipoprotein A-II,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34784,-0.0502758917657906,0.0202591777742296,-0.0899838802032807,-0.0105679033283005,0.0131072711012107
APOA2,Apolipoprotein A-II,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34784,-0.0255018332297954,0.0193142892542389,-0.0633578401681035,0.0123541737085128,0.186768593973934
APOA2,Apolipoprotein A-II,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34784,0.036100957630453,0.0244932083740338,-0.0119057307826532,0.0841076460435593,0.140560233541888
APOA2,Apolipoprotein A-II,Health and medical history,X120040.Fatigue severity over the past week,34790,-0.0266376287674522,0.0529275844049044,-0.130375694201065,0.0771004366661605,0.614784132463152
APOA2,Apolipoprotein A-II,Health and medical history,X120041.Waking unrefreshed severity over the past week,34790,0.0315912699030964,0.0529928548553287,-0.0722747256133478,0.135457265419541,0.551104445630818
APOA2,Apolipoprotein A-II,Health and medical history,X120042.Cognitive symptoms severity over the past week,34789,0.007225395770755,0.0565025952602753,-0.103519690939385,0.117970482480895,0.898250722693282
APOA2,Apolipoprotein A-II,Health and medical history,X120098.Mobility problems today,34793,0.119403730060783,0.0581513386384426,0.00542710632943552,0.233380353792131,0.0400872268619696
APOA2,Apolipoprotein A-II,Health and medical history,X120099.Self-care problems today,34793,0.212620573846627,0.0889644900474232,0.0382501733536779,0.386990974339577,0.0168836129647284
APOA2,Apolipoprotein A-II,Health and medical history,X120100.Problems doing usual activities,34793,0.0537882043104906,0.0565169109548341,-0.0569849411609842,0.164561349781965,0.341280736844128
APOA2,Apolipoprotein A-II,Health and medical history,X120101.Pain or discomfort today,34793,0.113599852436522,0.0527390516567921,0.0102313111892093,0.216968393683834,0.031282835474793
APOA2,Apolipoprotein A-II,Health and medical history,X120102.Anxiety or depression today,34793,0.0584760948952301,0.0665480426745662,-0.0719580687469196,0.18891025853738,0.379598998353728
APOA2,Apolipoprotein A-II,Health and medical history,X120103.Scale to indicate how health is today,34773,-0.00381397550595204,0.00657601834265301,-0.0167029714575519,0.00907502044564786,0.561949845863975
APOA2,Apolipoprotein A-II,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34770,0.0133305399591687,0.0681399080867628,-0.120223679890886,0.146884759809224,0.844903120440021
APOA2,Apolipoprotein A-II,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34760,0.0632759790019481,0.0704955956347127,-0.0748953884420888,0.201447346445985,0.369444239613332
APOA2,Apolipoprotein A-II,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34776,0.0403970598406802,0.0533019823763098,-0.0640748256168871,0.144868945298247,0.448548613279045
APOA2,Apolipoprotein A-II,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34778,-0.0198055890225958,0.0545592152963677,-0.126741651003476,0.0871304729582849,0.71661049823557
APOA2,Apolipoprotein A-II,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34785,0.00433226862173545,0.078056324663408,-0.148658127718544,0.157322664962015,0.95574065837822
APOA2,Apolipoprotein A-II,Health and medical history,X120109.Feeling bad about self over the last two weeks,34768,0.0836249273993356,0.075734543298346,-0.0648147774654226,0.232064632264094,0.269560686012782
APOA2,Apolipoprotein A-II,Health and medical history,X120110.Trouble concentrating over the last two weeks,34781,0.00128313238941346,0.0759557069920709,-0.147590053315045,0.150156318093872,0.986522447916271
APOA2,Apolipoprotein A-II,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34778,-0.0436616487328771,0.106914490105679,-0.253214049340008,0.165890751874254,0.683011001769618
APOA2,Apolipoprotein A-II,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34757,0.14475153775689,0.157740049213855,-0.164418958702267,0.453922034216046,0.358837341636558
APOA2,Apolipoprotein A-II,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32884,0.0981707481933712,0.0741302719817957,-0.0471245848909483,0.243466081277691,0.185485363444179
APOA2,Apolipoprotein A-II,Lifestyle factors,X1269.Exposure to tobacco smoke at home,47590,0.128084037116377,0.062989867132751,0.00462389753618483,0.251544176696569,0.0420257449360534
APOA2,Apolipoprotein A-II,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,46068,0.0535317541620507,0.0394589609560451,-0.0238078093117976,0.130871317635899,0.174912572444977
APOA2,Apolipoprotein A-II,Diet and food preferences,X1289.Cooked vegetable intake,48771,-0.0743806470072614,0.0275672942594034,-0.128412543755692,-0.0203487502588307,0.00697861524388712
APOA2,Apolipoprotein A-II,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48076,-0.0223374675501688,0.0287631866226876,-0.0787133133306365,0.034038378230299,0.437405005700263
APOA2,Apolipoprotein A-II,Diet and food preferences,X1309.Fresh fruit intake,48724,-0.0526001940070919,0.0283207176179903,-0.108108800538353,0.0029084125241691,0.0632828991237873
APOA2,Apolipoprotein A-II,Diet and food preferences,X1319.Dried fruit intake,47668,-0.0329436147405965,0.0282487698033287,-0.0883112035551208,0.0224239740739278,0.243550087790631
APOA2,Apolipoprotein A-II,Health and medical history,X134.Number of self-reported cancers,49351,0.0104500733402338,0.0438199444493751,-0.0754370177805414,0.096337164461009,0.811513144071897
APOA2,Apolipoprotein A-II,Health and medical history,X135.Number of self-reported non-cancer illnesses,49352,0.270552993103691,0.0285505683276612,0.214593879181475,0.326512107025907,2.91804345221202e-21
APOA2,Apolipoprotein A-II,Health and medical history,"X136.Number of operations, self-reported",49352,0.0822236262695497,0.0273446862128985,0.0286280412922686,0.135819211246831,0.0026422354046412
APOA2,Apolipoprotein A-II,Health and medical history,X137.Number of treatments or medications taken,49352,0.343857436881729,0.0275341685687845,0.289890466486912,0.397824407276547,1.17070067280132e-35
APOA2,Apolipoprotein A-II,Diet and food preferences,X1438.Bread intake,48812,-0.0108744406528843,0.00387193055243809,-0.0184634245356629,-0.00328545677010561,0.00498171232602994
APOA2,Apolipoprotein A-II,Diet and food preferences,X1458.Cereal intake,48525,-0.115572115667653,0.0268756707744978,-0.168248430385669,-0.0628958009496373,1.71441309650445e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X1488.Tea intake,48732,0.0105888556464746,0.00374311690998359,0.00325234650290673,0.0179253647900424,0.00467577257280341
APOA2,Apolipoprotein A-II,Diet and food preferences,X1498.Coffee intake,47858,-0.11783669518113,0.0273148572311671,-0.171373815354217,-0.064299575008042,1.61140122310981e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X1528.Water intake,47761,0.0749371481846298,0.0271417792215813,0.0217392609103304,0.128135035458929,0.00576897389343906
APOA2,Apolipoprotein A-II,Lifestyle factors,X1568.Average weekly red wine intake,42976,-0.0820894545671544,0.0319234874012077,-0.144659489873522,-0.0195194192607873,0.010137932499581
APOA2,Apolipoprotein A-II,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42977,-0.0308698952739571,0.0325805259307395,-0.0947277260982065,0.0329879355502923,0.343403061176033
APOA2,Apolipoprotein A-II,Lifestyle factors,X1588.Average weekly beer plus cider intake,43016,0.0877325709499404,0.036576000916927,0.0160436091527634,0.159421532747117,0.0164693611487566
APOA2,Apolipoprotein A-II,Lifestyle factors,X1598.Average weekly spirits intake,42963,0.022737292105344,0.0342963354926053,-0.0444835254601625,0.0899581096708504,0.507363657279697
APOA2,Apolipoprotein A-II,Lifestyle factors,X1608.Average weekly fortified wine intake,43003,-0.0377006965886715,0.0519037880885211,-0.139432121242173,0.0640307280648298,0.467632058590388
APOA2,Apolipoprotein A-II,Lifestyle factors,X1737.Childhood sunburn occasions,43881,-0.0356101258226692,0.0330947127991612,-0.100475762909025,0.0292555112636867,0.281942028905443
APOA2,Apolipoprotein A-II,Health and medical history,X1807.Father's age at death,47508,-0.00528880687320902,0.00359575780222455,-0.0123364921655691,0.0017588784191511,0.141349882476414
APOA2,Apolipoprotein A-II,Health and medical history,X1845.Mother's age,32180,0.0114017560031324,0.0171396195018773,-0.0221918982205472,0.044995410226812,0.505956005818228
APOA2,Apolipoprotein A-II,Health and medical history,X1873.Number of full brothers,48989,-0.0278823872102282,0.0260085699564411,-0.0788591843248528,0.0230944099043964,0.283712375686026
APOA2,Apolipoprotein A-II,Health and medical history,X1883.Number of full sisters,48993,0.0453416427425104,0.026018502471908,-0.0056546221024294,0.0963379075874501,0.0814069419577642
APOA2,Apolipoprotein A-II,Physical measures,X20015.Sitting height,49211,-0.0339220461678728,0.00481300846850138,-0.0433555427661355,-0.0244885495696101,1.87419467944292e-12
APOA2,Apolipoprotein A-II,Cognitive function,X20016.Fluid intelligence score,35879,-0.0591031109162622,0.042705850924919,-0.142806578729103,0.024600356896579,0.166417551566744
APOA2,Apolipoprotein A-II,Cognitive function,X20018.Prospective memory result,36174,0.0383441638909051,0.0525000633460468,-0.0645559602673466,0.141244288049157,0.465192144413712
APOA2,Apolipoprotein A-II,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35754,0.0034808003296663,0.00642810638151178,-0.00911828817809678,0.0160798888374294,0.588183453152947
APOA2,Apolipoprotein A-II,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35737,-0.00564688182538268,0.00649669878578166,-0.0183804114455147,0.00708664779474938,0.384773734156885
APOA2,Apolipoprotein A-II,Cognitive function,X20023.Mean time to correctly identify matches,49090,0.00980068002814688,0.0039345711211665,0.00208892063066054,0.0175124394256332,0.0127495673216745
APOA2,Apolipoprotein A-II,Health and medical history,X20107#1.Illnesses of father_Heart disease,46376,0.0101543937493294,0.00822297526199581,-0.00596263776418241,0.0262714252628412,0.216891780161554
APOA2,Apolipoprotein A-II,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,46002,-0.0442802585644648,0.0173030879867666,-0.0781943110185273,-0.0103662061104023,0.0105031598236912
APOA2,Apolipoprotein A-II,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45966,-0.0139842279489895,0.023277690886564,-0.0596085020866549,0.0316400461886759,0.54801018910686
APOA2,Apolipoprotein A-II,Health and medical history,X20107#12.Illnesses of father_Severe depression,45975,-0.0410670627592869,0.0219941259895083,-0.0841755496987231,0.00204142418014933,0.0618934293195818
APOA2,Apolipoprotein A-II,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,46001,-0.00703429407999307,0.0153153469642435,-0.0370523741299102,0.0229837859699241,0.646026787346604
APOA2,Apolipoprotein A-II,Health and medical history,X20107#2.Illnesses of father_Stroke,46141,0.00309464990169323,0.0103566476971432,-0.0172043795847074,0.0233936793880939,0.765090157535071
APOA2,Apolipoprotein A-II,Health and medical history,X20107#3.Illnesses of father_Lung cancer,46103,0.00265227913424679,0.0126035649487332,-0.0220507081652704,0.027355266433764,0.833327745050818
APOA2,Apolipoprotein A-II,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,46007,0.0211316287441672,0.0162793879234957,-0.0107759715858843,0.0530392290742187,0.194284388187594
APOA2,Apolipoprotein A-II,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,46156,0.00189687945965559,0.011121812165899,-0.0199018723855064,0.0236956313048175,0.864575804243597
APOA2,Apolipoprotein A-II,Health and medical history,X20107#8.Illnesses of father_High blood pressure,46145,0.0212413924218709,0.0103415597996004,0.000971935214654045,0.0415108496290877,0.0399925983697597
APOA2,Apolipoprotein A-II,Health and medical history,X20107#9.Illnesses of father_Diabetes,46032,0.00807586323995696,0.0147952398574997,-0.0209228068807425,0.0370745333606564,0.585181784616279
APOA2,Apolipoprotein A-II,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47330,-0.00287863600322789,0.00889287410585543,-0.0203086692507045,0.0145513972442488,0.746167825899135
APOA2,Apolipoprotein A-II,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,47191,0.00458341519738492,0.0116411321414852,-0.0182332037999261,0.0274000341946959,0.693788083770564
APOA2,Apolipoprotein A-II,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,47113,0.00803461505887618,0.0260567742717779,-0.0430366625138085,0.0591058926315608,0.757819353644934
APOA2,Apolipoprotein A-II,Health and medical history,X20110#12.Illnesses of mother_Severe depression,47135,-0.00519357646271926,0.0162548127503693,-0.037053009453443,0.0266658565280045,0.749343471868485
APOA2,Apolipoprotein A-II,Health and medical history,X20110#2.Illnesses of mother_Stroke,47279,0.00476240117342938,0.00974521858274725,-0.0143382272487552,0.023863029595614,0.625066361586999
APOA2,Apolipoprotein A-II,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,47155,-0.000608145608933326,0.0187452049431558,-0.0373487472975187,0.0361324560796521,0.974119347873572
APOA2,Apolipoprotein A-II,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,47139,0.0139995355937053,0.0158338139244612,-0.0170347396982387,0.0450338108856492,0.376624738098508
APOA2,Apolipoprotein A-II,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,47144,-0.0297374025969532,0.0139334047232017,-0.0570468758544286,-0.00242792933947783,0.0328356346899461
APOA2,Apolipoprotein A-II,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,47186,0.0203631356830174,0.0155637138854992,-0.010141743532561,0.0508680148985959,0.190763699405187
APOA2,Apolipoprotein A-II,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47319,-0.00331363040962262,0.00865192252529827,-0.0202713985592072,0.013644137739962,0.701729047548142
APOA2,Apolipoprotein A-II,Health and medical history,X20110#9.Illnesses of mother_Diabetes,47201,-0.0411237600667674,0.0133143497109791,-0.0672198855002865,-0.0150276346332483,0.00201354103406597
APOA2,Apolipoprotein A-II,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,44059,0.000271629521470446,0.0112872215747839,-0.0218513247651059,0.0223945838080468,0.980800905110636
APOA2,Apolipoprotein A-II,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43899,-0.0413336859144944,0.0396645684749398,-0.119076240125377,0.0364088682963877,0.297391343369756
APOA2,Apolipoprotein A-II,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43893,0.0101350773347952,0.0417618801702096,-0.0717182077988156,0.091988362468406,0.80825104387022
APOA2,Apolipoprotein A-II,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43924,0.00182680646658022,0.0172849607233647,-0.0320517165512146,0.035705329484375,0.915831637398578
APOA2,Apolipoprotein A-II,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43914,-0.0169740432184325,0.0236237085027906,-0.0632765118839021,0.0293284254470372,0.472449790043225
APOA2,Apolipoprotein A-II,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43945,0.0207934570968416,0.0187414798503299,-0.015939843409805,0.0575267576034881,0.267237572933479
APOA2,Apolipoprotein A-II,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43914,0.0389596982248257,0.0211135206610647,-0.00242280227086097,0.0803421987205125,0.065021430025376
APOA2,Apolipoprotein A-II,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43907,0.015085266069019,0.0213151421860149,-0.0266924126155701,0.0568629447536081,0.479127053703638
APOA2,Apolipoprotein A-II,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43926,-0.000151447536049036,0.0172109834850686,-0.0338849751667835,0.0335820800946854,0.992979248348914
APOA2,Apolipoprotein A-II,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43945,0.0168825652203441,0.0205417578289651,-0.0233792801244275,0.0571444105651157,0.411166646313573
APOA2,Apolipoprotein A-II,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,44091,0.00766080159143931,0.00952801668789802,-0.0110141111168408,0.0263357142997194,0.421393065117018
APOA2,Apolipoprotein A-II,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,44000,0.00398574358970577,0.0130250631832785,-0.0215433802495201,0.0295148674289317,0.759604607488872
APOA2,Apolipoprotein A-II,Mental health,X20127.Neuroticism score,45033,0.0210828690264363,0.0272511081370991,-0.0323293029222779,0.0744950409751506,0.439148281550644
APOA2,Apolipoprotein A-II,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35879,-0.0263947972869507,0.0433878276029567,-0.111434939388746,0.0586453448148444,0.542978935640095
APOA2,Apolipoprotein A-II,Lifestyle factors,X20161.Pack years of smoking,36038,0.0131591848477168,0.00658621791502237,0.000250197734272924,0.0260681719611606,0.0457574495029046
APOA2,Apolipoprotein A-II,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36038,0.0135564179891149,0.00680562616137324,0.000217390712823335,0.0268954452654065,0.0464169969478027
APOA2,Apolipoprotein A-II,Cognitive function,X20191.Fluid intelligence score,33664,0.015105445683044,0.0538937925199846,-0.0905263876561259,0.120737279022214,0.779274367529981
APOA2,Apolipoprotein A-II,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33665,0.0352491555691815,0.0550332161694715,-0.0726159481229826,0.143114259261346,0.521876006761875
APOA2,Apolipoprotein A-II,Cognitive function,X20240.Maximum digits remembered correctly,33114,-0.0152375378032033,0.0582458681092005,-0.129399439297236,0.0989243636908297,0.793638073532776
APOA2,Apolipoprotein A-II,Physical measures,X20255.Spirometry QC measure,44098,-0.029902839261348,0.0348744167298871,-0.0982566960519268,0.0384510175292308,0.391213655275682
APOA2,Apolipoprotein A-II,Eye measures,X20261.avMSE,33761,0.0136315574111329,0.0072362118482736,-0.00055141781148332,0.0278145326337492,0.0596558539615009
APOA2,Apolipoprotein A-II,Eye measures,X20262.Myopia diagnosis,33761,-0.10409090118532,0.0673723950743536,-0.236140795531053,0.0279589931604132,0.122413586785953
APOA2,Apolipoprotein A-II,NMR metabolomics,X20280.Glucose-lactate,40503,-0.00919815291732453,0.00488685473346445,-0.0187763881949148,0.000380082360265791,0.0598313274872426
APOA2,Apolipoprotein A-II,NMR metabolomics,X20281.Spectrometer-corrected alanine,40526,-0.00474850159620559,0.00500719784739756,-0.0145626093771048,0.00506560618469362,0.342979097468331
APOA2,Apolipoprotein A-II,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35487,-0.0180515449552733,0.0295139974383385,-0.0758989799344169,0.0397958900238702,0.54080695037965
APOA2,Apolipoprotein A-II,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35487,-0.0141409309448027,0.055582822826837,-0.123083263685403,0.0948014017957978,0.799185679603808
APOA2,Apolipoprotein A-II,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35488,-0.0179373049921161,0.0900398668989724,-0.194415444114102,0.15854083412987,0.842100889192581
APOA2,Apolipoprotein A-II,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35488,-0.0148858432463096,0.0271406869715568,-0.0680815897105609,0.0383099032179416,0.583388912319788
APOA2,Apolipoprotein A-II,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35488,-0.0414951786173318,0.0575106149559738,-0.15421598393104,0.0712256266963768,0.470615161151898
APOA2,Apolipoprotein A-II,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35491,-0.039002600618901,0.0700293785936836,-0.176260182662521,0.0982549814247188,0.577583939269143
APOA2,Apolipoprotein A-II,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35491,-0.00596721341260132,0.0454019118661685,-0.0949549606702916,0.083020533845089,0.895438657419927
APOA2,Apolipoprotein A-II,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35491,0.00309587553726768,0.0528099449627475,-0.100411616589717,0.106603367664253,0.953254279137791
APOA2,Apolipoprotein A-II,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35491,0.129873599202132,0.0825309483141836,-0.0318870594936676,0.291634257897932,0.11562206590047
APOA2,Apolipoprotein A-II,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35491,-0.0575986228201452,0.0944692835945714,-0.242758418665505,0.127561173025215,0.542077640036745
APOA2,Apolipoprotein A-II,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35491,0.0382160303036821,0.0586502030026258,-0.0767383675814646,0.153170428188829,0.514687889702751
APOA2,Apolipoprotein A-II,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35491,0.146816139154324,0.0960894886899402,-0.0415192586779582,0.335151536986607,0.126584986019757
APOA2,Apolipoprotein A-II,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35491,0.0586893300809441,0.0681710369624717,-0.0749259023655004,0.192304562527389,0.38931875469223
APOA2,Apolipoprotein A-II,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35491,0.0018892914100251,0.0978816361978634,-0.189958715537787,0.193737298357837,0.984600962430281
APOA2,Apolipoprotein A-II,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35491,-0.00527622978558846,0.0369683042657723,-0.0777341061465022,0.0671816465753253,0.886513464297631
APOA2,Apolipoprotein A-II,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35491,-0.0602571359703293,0.070058042659813,-0.197570899583563,0.0770566276429042,0.389764985872319
APOA2,Apolipoprotein A-II,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35492,0.0246534407725494,0.116761528248983,-0.204199154595457,0.253506036140556,0.832782108309266
APOA2,Apolipoprotein A-II,Diet and food preferences,X20600.Liking for adding salt to foods,35359,-0.0847262920292237,0.0466451567371707,-0.176150799234078,0.00669821517563092,0.069357553099702
APOA2,Apolipoprotein A-II,Diet and food preferences,X20601.Liking for aniseed,35359,-0.0480493209706458,0.046179813524305,-0.138561755478284,0.042463113536992,0.298156319101339
APOA2,Apolipoprotein A-II,Diet and food preferences,X20602.Liking for apple juice,35359,-0.0466370305976564,0.0459041599103231,-0.13660918402189,0.0433351228265769,0.309685869306017
APOA2,Apolipoprotein A-II,Diet and food preferences,X20603.Liking for apples,35359,-0.00555295033327811,0.0475682120717494,-0.0987866459939069,0.0876807453273506,0.907072610817405
APOA2,Apolipoprotein A-II,Diet and food preferences,X20604.Liking for asparagus,35359,-0.0445729315576931,0.0469253453937841,-0.13654660852951,0.0474007454141238,0.34221610163062
APOA2,Apolipoprotein A-II,Diet and food preferences,X20605.Liking for aubergine,35359,-0.00967443794863925,0.0460159282320214,-0.0998656572834013,0.0805167813861228,0.833486485121556
APOA2,Apolipoprotein A-II,Diet and food preferences,X20606.Liking for avocados,35359,0.0722865413091505,0.0470170764976936,-0.019866928626329,0.16444001124463,0.124233830861173
APOA2,Apolipoprotein A-II,Diet and food preferences,X20607.Liking for bacon,35359,-0.13450222234994,0.0469110635682137,-0.226447906943639,-0.0425565377562407,0.00415560367288074
APOA2,Apolipoprotein A-II,Diet and food preferences,X20608.Liking for baked or steamed fish,35359,-0.0327034056260727,0.0477540924117262,-0.126301426753056,0.0608946155009108,0.493477374487431
APOA2,Apolipoprotein A-II,Diet and food preferences,X20609.Liking for bananas,35359,-0.0217249585669082,0.0483799846066733,-0.116549728395988,0.0730998112621715,0.653412491515343
APOA2,Apolipoprotein A-II,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35359,-0.196342771890815,0.0468782458568334,-0.288224133770209,-0.104461410011422,2.84906813829821e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20611.Liking for beef steak,35359,-0.267264656432637,0.0471164206623688,-0.359612840930879,-0.174916471934394,1.47187571422942e-08
APOA2,Apolipoprotein A-II,Diet and food preferences,X20612.Liking for beetroot,35359,0.0334534777611907,0.0468644817342708,-0.0584009064379801,0.125307861960361,0.475356666801266
APOA2,Apolipoprotein A-II,Diet and food preferences,X20613.Liking for bell pepper,35359,9.13104979621318e-05,0.046090159302754,-0.0902454017354357,0.0904280227313599,0.998419353906489
APOA2,Apolipoprotein A-II,Diet and food preferences,X20614.Liking for bicycling,35359,-0.0154687367933739,0.0458254259942767,-0.105286571742156,0.0743490981554085,0.735707845071026
APOA2,Apolipoprotein A-II,Diet and food preferences,X20615.Liking for biscuits,35359,-0.0478994915351572,0.0464129721673095,-0.138868916983084,0.0430699339127694,0.302099496107494
APOA2,Apolipoprotein A-II,Diet and food preferences,X20616.Liking for bitter foods,35359,-0.0608113446884004,0.046426872419553,-0.151808014630724,0.0301853252539234,0.1903019780944
APOA2,Apolipoprotein A-II,Diet and food preferences,X20617.Liking for bitter or ale,35359,-0.0469741142512059,0.0478735846906784,-0.140806340244936,0.0468581117425237,0.326526989155237
APOA2,Apolipoprotein A-II,Diet and food preferences,X20618.Liking for black olives,35359,-0.0531892368289184,0.0467241671460598,-0.144768604435196,0.0383901307773589,0.255011684554644
APOA2,Apolipoprotein A-II,Diet and food preferences,X20619.Liking for black pepper,35359,0.00985627291222498,0.0468820631290484,-0.0820325708207099,0.10174511664516,0.833490849153708
APOA2,Apolipoprotein A-II,Diet and food preferences,X20620.Liking for blue cheese,35359,0.0064105940710982,0.0462825882828421,-0.0843032789632722,0.0971244671054686,0.889842020859008
APOA2,Apolipoprotein A-II,Diet and food preferences,X20621.Liking for bolognese sauce,35359,-0.131541889141248,0.0467276609349255,-0.223128104573702,-0.0399556737087937,0.00489207354560045
APOA2,Apolipoprotein A-II,Diet and food preferences,X20622.Liking for broad beans,35359,0.00184609588139571,0.0470629675585344,-0.0903973205333316,0.0940895122961231,0.96871141022707
APOA2,Apolipoprotein A-II,Diet and food preferences,X20623.Liking for broccoli,35359,-0.0226352463218995,0.0478680304692683,-0.116456586041665,0.0711860933978665,0.636324322392938
APOA2,Apolipoprotein A-II,Diet and food preferences,X20624.Liking for brown rice,35359,0.000552624086688441,0.0466316934400723,-0.0908454950558532,0.0919507432292301,0.990545014214329
APOA2,Apolipoprotein A-II,Diet and food preferences,X20625.Liking for brussel sprouts,35359,0.0228986422415936,0.0469061112215356,-0.0690373357526162,0.114834620235803,0.625439482275663
APOA2,Apolipoprotein A-II,Diet and food preferences,X20626.Liking for burgers (meat),35359,-0.189633049773235,0.0464124178685043,-0.280601388795504,-0.0986647107509669,4.44783178224287e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20627.Liking for burn of spicy foods,35359,-0.0870304136975177,0.0458547845458828,-0.176905791407448,0.00284496401241247,0.057748468702105
APOA2,Apolipoprotein A-II,Diet and food preferences,X20628.Liking for butter on bread,35359,-0.11766037420032,0.04735811361785,-0.210482276891306,-0.0248384715093343,0.0130003926657512
APOA2,Apolipoprotein A-II,Diet and food preferences,X20629.Liking for butternut squash,35359,-0.0558947374897186,0.0463607743901347,-0.146761855294383,0.0349723803149453,0.22799989296348
APOA2,Apolipoprotein A-II,Diet and food preferences,X20630.Liking for cabbage,35359,-0.0284692279716846,0.0471099833942004,-0.120804795424317,0.0638663394809482,0.545657093371859
APOA2,Apolipoprotein A-II,Diet and food preferences,X20631.Liking for cake,35359,0.00618472089449799,0.0463186873362984,-0.0845999062846468,0.0969693480736428,0.893782248521111
APOA2,Apolipoprotein A-II,Diet and food preferences,X20632.Liking for cake icing,35359,-0.016354153288402,0.0462352271897617,-0.106975198580335,0.0742668920035309,0.723563622103487
APOA2,Apolipoprotein A-II,Diet and food preferences,X20633.Liking for capers,35359,-0.0177797018062869,0.0463323678648807,-0.108591142821453,0.0730317392088793,0.701182511689287
APOA2,Apolipoprotein A-II,Diet and food preferences,X20634.Liking for cauliflower,35359,0.069218604231512,0.0473856188625944,-0.0236572087391731,0.162094417202197,0.144134740445632
APOA2,Apolipoprotein A-II,Diet and food preferences,X20635.Liking for cereal or granola bar,35359,0.00815545733080806,0.0461329076952749,-0.0822650417519307,0.0985759564135469,0.859685620154283
APOA2,Apolipoprotein A-II,Diet and food preferences,X20636.Liking for cheesecake,35359,0.00225419390401741,0.0461123501533578,-0.0881260123965638,0.0926344002045986,0.961012672712044
APOA2,Apolipoprotein A-II,Diet and food preferences,X20637.Liking for cherries,35359,-0.0495337708829514,0.0500676082349937,-0.147666283023539,0.0485987412576363,0.322536842806648
APOA2,Apolipoprotein A-II,Diet and food preferences,X20638.Liking for chicken,35359,-0.148347329516409,0.0485558535169286,-0.243516802409589,-0.0531778566232292,0.00225881168766316
APOA2,Apolipoprotein A-II,Diet and food preferences,X20639.Liking for chilli pepper,35359,-0.0346447636932561,0.0464032657361966,-0.125595164536202,0.0563056371496893,0.455332447421099
APOA2,Apolipoprotein A-II,Diet and food preferences,X20640.Liking for chips or french fries,35359,-0.0898655378580615,0.0470266372348379,-0.182037746838344,0.00230667112222074,0.0560574447984616
APOA2,Apolipoprotein A-II,Diet and food preferences,X20641.Liking for cigarette smoking,35359,0.0748520635807061,0.0798594626015264,-0.0816724831182856,0.231376610279698,0.348642389511153
APOA2,Apolipoprotein A-II,Diet and food preferences,X20642.Liking for cod,35359,-0.0451929249479599,0.0482457251266388,-0.139754546196172,0.0493686963002521,0.348937332679592
APOA2,Apolipoprotein A-II,Diet and food preferences,X20643.Liking for coffee with sugar,35359,-0.0696752298009442,0.0507106273889794,-0.169068059483344,0.0297175998814554,0.169498883025927
APOA2,Apolipoprotein A-II,Diet and food preferences,X20644.Liking for coffee without sugar,35359,-0.0101029080168835,0.0476291113379667,-0.103455966239298,0.0832501502055313,0.832023372663472
APOA2,Apolipoprotein A-II,Diet and food preferences,X20645.Liking for coriander,35359,-0.0130993080192849,0.0463671444296289,-0.103978911101357,0.0777802950627877,0.777559893604001
APOA2,Apolipoprotein A-II,Diet and food preferences,X20646.Liking for corn flakes,35359,-0.0196887836065751,0.0461079792108617,-0.110060422859864,0.0706828556467139,0.669383574900532
APOA2,Apolipoprotein A-II,Diet and food preferences,X20647.Liking for cream,35359,-0.123934649103037,0.0462678171650526,-0.21461957074654,-0.0332497274595342,0.00741190879044023
APOA2,Apolipoprotein A-II,Diet and food preferences,X20648.Liking for croissant,35359,0.0140898760177083,0.0462927843926056,-0.0766439813917987,0.104823733427215,0.760860566787427
APOA2,Apolipoprotein A-II,Diet and food preferences,X20649.Liking for cucumber,35359,-0.0238233341793134,0.0466973658872721,-0.115350171318367,0.0677035029597399,0.609954573265421
APOA2,Apolipoprotein A-II,Diet and food preferences,X20650.Liking for curry,35359,-0.0839739630710495,0.0464780580451147,-0.175070956839474,0.00712303069737535,0.0708509769610167
APOA2,Apolipoprotein A-II,Diet and food preferences,X20651.Liking for dairy products,35359,-0.123078217491611,0.046861696209311,-0.214927142061861,-0.0312292929213613,0.00865034789007818
APOA2,Apolipoprotein A-II,Diet and food preferences,X20652.Liking for dark chocolate,35359,-0.0932740012190218,0.0470557831560249,-0.185503336204831,-0.001044666233213,0.047501189225067
APOA2,Apolipoprotein A-II,Diet and food preferences,X20653.Liking for diet fizzy drinks,35359,-0.0384614119825202,0.0485402005212954,-0.133600205004259,0.0566773810392187,0.428180143439174
APOA2,Apolipoprotein A-II,Diet and food preferences,X20654.Liking for dried fruit,35359,-0.0337763549794486,0.0468168165105408,-0.125537315340109,0.0579846053812113,0.470655327326769
APOA2,Apolipoprotein A-II,Diet and food preferences,X20655.Liking for eggs,35359,-0.0223937411409513,0.0480680139019114,-0.116607048388698,0.071819566106795,0.64132063757406
APOA2,Apolipoprotein A-II,Diet and food preferences,X20656.Liking for exercising alone,35359,0.0534582343594002,0.0462511736410536,-0.037194065977065,0.144110534695865,0.24779785236592
APOA2,Apolipoprotein A-II,Diet and food preferences,X20657.Liking for exercising with others,35359,0.0727406445929619,0.0461692911472245,-0.0177511660555982,0.163232455241522,0.115187836088646
APOA2,Apolipoprotein A-II,Diet and food preferences,X20658.Liking for extra virgin olive oil,35359,-0.015148856088153,0.0468210056231153,-0.106918027109459,0.0766203149331529,0.746291036251504
APOA2,Apolipoprotein A-II,Diet and food preferences,X20659.Liking for fatty foods,35359,-0.0652298601215796,0.0467363288655806,-0.156833064698118,0.0263733444549585,0.162855410417337
APOA2,Apolipoprotein A-II,Diet and food preferences,X20660.Liking for fresh tomatoes,35359,-0.0133345908557295,0.0506688390889175,-0.112645515470008,0.0859763337585489,0.792427257681576
APOA2,Apolipoprotein A-II,Diet and food preferences,X20661.Liking for fried chicken,35359,-0.0903902535222292,0.0460806757154306,-0.180708377924473,-7.21291199852203e-05,0.0498581192327072
APOA2,Apolipoprotein A-II,Diet and food preferences,X20662.Liking for fried or battered fish,35359,-0.113201933287014,0.0469898366750338,-0.205302013170081,-0.021101853403948,0.0160222900487678
APOA2,Apolipoprotein A-II,Diet and food preferences,X20663.Liking for fruit,35359,0.0140081768969087,0.0532913916588206,-0.0904429507543798,0.118459304548197,0.792667259868321
APOA2,Apolipoprotein A-II,Diet and food preferences,X20664.Liking for garlic,35359,0.00579013606735975,0.0466981064585917,-0.08573815259148,0.0973184247261994,0.901326599180381
APOA2,Apolipoprotein A-II,Diet and food preferences,X20665.Liking for gherkins,35359,0.00316424034810442,0.0465019134001459,-0.0879795099161816,0.0943079906123905,0.945751720194844
APOA2,Apolipoprotein A-II,Diet and food preferences,X20666.Liking for globe artichoke,35359,0.0726866711402349,0.0466011707111843,-0.0186516234536863,0.164024965734156,0.118867863497164
APOA2,Apolipoprotein A-II,Diet and food preferences,X20667.Liking for goat's cheese,35359,0.00584296703685909,0.0462979986912378,-0.084901110397967,0.0965870444716852,0.899575004082916
APOA2,Apolipoprotein A-II,Diet and food preferences,X20668.Liking for going to a cafe,35359,-0.0161349369858969,0.0465432515915783,-0.10735971010539,0.0750898361335966,0.728854522448673
APOA2,Apolipoprotein A-II,Diet and food preferences,X20669.Liking for going to the gym,35359,0.00944583015312998,0.0464091089908992,-0.0815160234690325,0.100407683775292,0.838724425146529
APOA2,Apolipoprotein A-II,Diet and food preferences,X20670.Liking for going to the pub,35359,-0.0385286621303501,0.0467870096053969,-0.130231200956928,0.0531738766962278,0.410260966792008
APOA2,Apolipoprotein A-II,Diet and food preferences,X20671.Liking for grapefruit,35359,-0.0118995547764323,0.0463918275863821,-0.102827536845741,0.0790284272928766,0.797572502991575
APOA2,Apolipoprotein A-II,Diet and food preferences,X20672.Liking for green olives,35359,-0.0234636957267191,0.0466227077534877,-0.114844202923555,0.0679168114701169,0.614794186618531
APOA2,Apolipoprotein A-II,Diet and food preferences,X20673.Liking for haddock,35359,-0.0286348857375507,0.0485622599902038,-0.12381691531835,0.0665471438432487,0.55544490362461
APOA2,Apolipoprotein A-II,Diet and food preferences,X20674.Liking for ham,35359,-0.176858306082409,0.0470834567571095,-0.269141881326344,-0.0845747308384742,0.000174055250560857
APOA2,Apolipoprotein A-II,Diet and food preferences,X20675.Liking for hard cheese,35359,0.0314820424393094,0.0476331940286553,-0.0618790178568549,0.124843102735474,0.508684153201521
APOA2,Apolipoprotein A-II,Diet and food preferences,X20676.Liking for herring,35359,-0.0220452480318638,0.046712595900903,-0.113601935997634,0.0695114399339061,0.636990842604772
APOA2,Apolipoprotein A-II,Diet and food preferences,X20677.Liking for honey,35359,-0.0173440969251473,0.046607558729757,-0.108694912035471,0.0740067181851764,0.709808453330603
APOA2,Apolipoprotein A-II,Diet and food preferences,X20678.Liking for horseradish or wasabi,35359,-0.0185149247214624,0.0465911196908044,-0.109833519315439,0.0728036698725142,0.691092405517267
APOA2,Apolipoprotein A-II,Diet and food preferences,X20679.Liking for ice cream,35359,-0.0144486319235733,0.0465638824899016,-0.105713841603781,0.0768165777566338,0.75634563485786
APOA2,Apolipoprotein A-II,Diet and food preferences,X20680.Liking for jam,35359,-0.0801457322644491,0.0463396399663855,-0.170971426598565,0.0106799620696665,0.0837646610871573
APOA2,Apolipoprotein A-II,Diet and food preferences,X20681.Liking for kiwi fruit,35359,0.0086677183294055,0.0465678378779734,-0.0826052439114223,0.0999406805702333,0.852348163360728
APOA2,Apolipoprotein A-II,Diet and food preferences,X20682.Liking for lager,35359,-0.0228117867907892,0.0473163427212128,-0.115551818524366,0.0699282449427879,0.629743373010055
APOA2,Apolipoprotein A-II,Diet and food preferences,X20683.Liking for lamb,35359,-0.233056904850955,0.0478192174504758,-0.326782571053887,-0.139331238648022,1.12267258052949e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20684.Liking for lemons,35359,-0.00715706799114119,0.0462287215640564,-0.0977653622566917,0.0834512262744093,0.876969368048706
APOA2,Apolipoprotein A-II,Diet and food preferences,X20685.Liking for lentils or beans,35359,0.0394746566755071,0.0471728544784963,-0.0529841381023456,0.13193345145336,0.402732569112728
APOA2,Apolipoprotein A-II,Diet and food preferences,X20686.Liking for liver,35359,-0.137175560999308,0.0467262231045487,-0.228758958284223,-0.0455921637143922,0.00333995355065539
APOA2,Apolipoprotein A-II,Diet and food preferences,X20687.Liking for mackerel,35359,0.0283402788473907,0.0467069477248589,-0.0632053386933327,0.119885896388114,0.544027297755574
APOA2,Apolipoprotein A-II,Diet and food preferences,X20688.Liking for marzipan,35359,0.00276571899757986,0.045906070067083,-0.0872101783339028,0.0927416163290625,0.951960591267914
APOA2,Apolipoprotein A-II,Diet and food preferences,X20689.Liking for mayonnaise,35359,0.025572199498049,0.0461430573784503,-0.0648681929637137,0.116012591959812,0.579466304410788
APOA2,Apolipoprotein A-II,Diet and food preferences,X20690.Liking for melon,35359,-0.0604651649013837,0.0481247100047758,-0.154789596510744,0.033859266707977,0.209009024460986
APOA2,Apolipoprotein A-II,Diet and food preferences,X20691.Liking for milk chocolate,35359,-0.019916590785308,0.0462173499634583,-0.110502596713686,0.0706694151430703,0.666532026177901
APOA2,Apolipoprotein A-II,Diet and food preferences,X20692.Liking for mushrooms,35359,-0.0126757110250762,0.0483430818439309,-0.107428151439181,0.0820767293890285,0.793173555356931
APOA2,Apolipoprotein A-II,Diet and food preferences,X20694.Liking for orange juice,35359,0.00494771707599704,0.0467118595156482,-0.0866075275746734,0.0965029617266675,0.915649329120864
APOA2,Apolipoprotein A-II,Diet and food preferences,X20695.Liking for oranges,35359,-0.0652625582817841,0.047720854405478,-0.158795432916521,0.0282703163529527,0.171490405940756
APOA2,Apolipoprotein A-II,Diet and food preferences,X20696.Liking for pasta,35359,-0.0278243997400267,0.0471931643324019,-0.120323001831534,0.064674202351481,0.555490292549079
APOA2,Apolipoprotein A-II,Diet and food preferences,X20697.Liking for pears,35359,-0.0503777346330528,0.0478560438740652,-0.144175580626221,0.0434201113601151,0.29252291822296
APOA2,Apolipoprotein A-II,Diet and food preferences,X20698.Liking for pizza,35359,-0.117643763856593,0.0464145988997501,-0.208616377700103,-0.0266711500130828,0.0112812289805779
APOA2,Apolipoprotein A-II,Diet and food preferences,X20699.Liking for plain yogurt,35359,-0.048212913542038,0.0470140221464988,-0.140360396949176,0.0439345698650997,0.30516728000397
APOA2,Apolipoprotein A-II,Diet and food preferences,X20700.Liking for plums,35359,-0.0389260405717967,0.0477965405857554,-0.132607260119877,0.0547551789762839,0.415440895982731
APOA2,Apolipoprotein A-II,Diet and food preferences,X20701.Liking for pollock,35359,0.0217691022173166,0.0463123924165608,-0.0690031869191425,0.112541391353776,0.638336529870148
APOA2,Apolipoprotein A-II,Diet and food preferences,X20702.Liking for pork chop,35359,-0.200830844456901,0.0465865177149794,-0.292140419178261,-0.109521269735541,1.65110903309532e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20703.Liking for porridge,35359,-0.0820465851766094,0.0474861513220271,-0.175119441767783,0.0110262714145638,0.0840741904122536
APOA2,Apolipoprotein A-II,Diet and food preferences,X20704.Liking for potato crisps,35359,-0.0281295703940388,0.0465720081123862,-0.119410706294316,0.0631515655062381,0.545864792707316
APOA2,Apolipoprotein A-II,Diet and food preferences,X20705.Liking for potatoes,35359,-0.0773659873377737,0.0471024170447161,-0.169686724745417,0.0149547500698698,0.100536316912694
APOA2,Apolipoprotein A-II,Diet and food preferences,X20706.Liking for prawns,35359,-0.0413770706500945,0.0477461934467911,-0.134959609805805,0.052205468505616,0.386192469817786
APOA2,Apolipoprotein A-II,Diet and food preferences,X20707.Liking for raw carrots,35359,0.0594421344474219,0.0467760249764904,-0.0322388745064992,0.151123143401343,0.203854204153366
APOA2,Apolipoprotein A-II,Diet and food preferences,X20708.Liking for red meat,35359,-0.230588026822397,0.0469988910876435,-0.322705853354178,-0.138470200290616,9.52244013418206e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20709.Liking for red wine,35359,-0.0504898039964096,0.0469272019993731,-0.142467119915181,0.0414875119223616,0.282006260259975
APOA2,Apolipoprotein A-II,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35359,-0.0336533693884186,0.0483118135526552,-0.128344523951623,0.0610377851747856,0.486087748635386
APOA2,Apolipoprotein A-II,Diet and food preferences,X20711.Liking for roast chicken,35359,-0.179347036233817,0.048524466527436,-0.274454990627592,-0.0842390818400428,0.000220914905373083
APOA2,Apolipoprotein A-II,Diet and food preferences,X20712.Liking for salad dressing,35359,-0.0895477120838429,0.0462550844735009,-0.180207677651905,0.00111225348421877,0.0529190699150171
APOA2,Apolipoprotein A-II,Diet and food preferences,X20713.Liking for salad leaves,35359,0.0774871603758034,0.0477284866303827,-0.0160606734197466,0.171034994171353,0.104533932385389
APOA2,Apolipoprotein A-II,Diet and food preferences,X20714.Liking for salami,35359,-0.169646184247375,0.0468416496646019,-0.261455817589995,-0.0778365509047556,0.000295034381385124
APOA2,Apolipoprotein A-II,Diet and food preferences,X20715.Liking for salmon,35359,-0.0924932851592535,0.0492727815082944,-0.18906793691551,0.00408136659700348,0.06054233426234
APOA2,Apolipoprotein A-II,Diet and food preferences,X20716.Liking for salty foods,35359,-0.0596373185179711,0.0460646206722922,-0.149923975035664,0.0306493379997216,0.19549137085098
APOA2,Apolipoprotein A-II,Diet and food preferences,X20717.Liking for salty pretzels,35359,-0.0329538874708241,0.0460818155225511,-0.123274245895024,0.057366470953376,0.474563898777065
APOA2,Apolipoprotein A-II,Diet and food preferences,X20718.Liking for sardines,35359,0.0237900399040542,0.0466265730827656,-0.0675980433381663,0.115178123146275,0.609912182841492
APOA2,Apolipoprotein A-II,Diet and food preferences,X20719.Liking for sausages (meat),35359,-0.147176439166936,0.0467853775838175,-0.238875779231218,-0.055477099102654,0.0016643473220212
APOA2,Apolipoprotein A-II,Diet and food preferences,X20720.Liking for savoury biscuits,35359,-0.0186017585028174,0.0462163859070503,-0.109185874880636,0.0719823578750012,0.687335426081168
APOA2,Apolipoprotein A-II,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35359,-0.0534200821057633,0.0466838030485217,-0.144920336080866,0.0380801718693392,0.25254545413836
APOA2,Apolipoprotein A-II,Diet and food preferences,X20722.Liking for skimmed milk,35359,-0.0222442579789139,0.0462785353426867,-0.11295018725058,0.068461671292752,0.630774981456645
APOA2,Apolipoprotein A-II,Diet and food preferences,X20723.Liking for smoked fish,35359,-0.0333525808664355,0.0467569985206595,-0.124996297966928,0.0582911362340571,0.475676409011575
APOA2,Apolipoprotein A-II,Diet and food preferences,X20724.Liking for soft cheese,35359,-0.0416543426705349,0.0464423792433053,-0.132681405987413,0.0493727206463434,0.369805368238248
APOA2,Apolipoprotein A-II,Diet and food preferences,X20725.Liking for soy sauce,35359,-0.0788937760602112,0.0464959141342617,-0.170025767763364,0.0122382156429417,0.0897870293991627
APOA2,Apolipoprotein A-II,Diet and food preferences,X20726.Liking for soya milk,35359,-0.00333414689715261,0.0464638030279595,-0.0944032008319532,0.087734907037648,0.94279687473656
APOA2,Apolipoprotein A-II,Diet and food preferences,X20727.Liking for spicy foods,35359,-0.0825357791385768,0.0466256231729533,-0.173922000557565,0.00885044228041169,0.0767465265848813
APOA2,Apolipoprotein A-II,Diet and food preferences,X20728.Liking for spinach,35359,-0.047117224724935,0.0471922680457668,-0.139614070094638,0.045379620644768,0.318119907042784
APOA2,Apolipoprotein A-II,Diet and food preferences,X20729.Liking for spirits,35359,-0.0212631866096174,0.0466800232174497,-0.112756032115819,0.0702296588965841,0.648758914590417
APOA2,Apolipoprotein A-II,Diet and food preferences,X20730.Liking for strawberries,35359,-0.110788597935593,0.0506618933134965,-0.210085908830046,-0.0114912870411402,0.028792948973423
APOA2,Apolipoprotein A-II,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35359,-0.0696004184847218,0.0475223030310865,-0.162744132425651,0.0235432954562078,0.14308543509463
APOA2,Apolipoprotein A-II,Diet and food preferences,X20732.Liking for sweet foods,35359,-0.0366232959601832,0.0458374439505693,-0.126464686103299,0.0532180941829326,0.424331631793892
APOA2,Apolipoprotein A-II,Diet and food preferences,X20733.Liking for taking the stairs,35359,0.0154463349471906,0.0476507037542485,-0.0779490444111365,0.108841714305518,0.745829778386168
APOA2,Apolipoprotein A-II,Diet and food preferences,X20734.Liking for tea with sugar,35359,0.00882294405718816,0.056310507550411,-0.101545650741617,0.119191538855994,0.875499196596059
APOA2,Apolipoprotein A-II,Diet and food preferences,X20735.Liking for tea without sugar,35359,0.00782955096933312,0.0485644331448903,-0.0873567379946519,0.103015839933318,0.871925532458085
APOA2,Apolipoprotein A-II,Diet and food preferences,X20736.Liking for tomato ketchup,35359,-0.0336539593808014,0.0460040599504783,-0.123821916883739,0.056513998122136,0.464475244442302
APOA2,Apolipoprotein A-II,Diet and food preferences,X20737.Liking for tinned tuna,35359,-0.0402830240409256,0.0466433246995567,-0.131703940452057,0.0511378923702055,0.38781952953872
APOA2,Apolipoprotein A-II,Diet and food preferences,X20738.Liking for turnip (white),35359,-0.00580072103516104,0.0464287420981541,-0.0968010555475431,0.085199613477221,0.900576596996509
APOA2,Apolipoprotein A-II,Diet and food preferences,X20739.Liking for vegetables,35359,0.0247221829219178,0.0513040974528473,-0.0758338480856628,0.125278213929498,0.629911586673363
APOA2,Apolipoprotein A-II,Diet and food preferences,X20740.Liking for vinegar,35359,-0.115443135480039,0.0462907438625193,-0.206172993450576,-0.0247132775095008,0.012661889717581
APOA2,Apolipoprotein A-II,Diet and food preferences,X20741.Liking for watching television,35359,-0.0745664250086453,0.046443874478831,-0.165596418987154,0.0164635689698635,0.108431391067334
APOA2,Apolipoprotein A-II,Diet and food preferences,X20742.Liking for whisky,35359,-0.0282426670648346,0.0479161807131121,-0.122158381262534,0.0656730471328651,0.555602427297336
APOA2,Apolipoprotein A-II,Diet and food preferences,X20743.Liking for white bread,35359,-0.0586994930491006,0.0462041704681449,-0.149259667166665,0.0318606810684634,0.203976981001358
APOA2,Apolipoprotein A-II,Diet and food preferences,X20744.Liking for white rice,35359,-0.0511530069449543,0.04636527153321,-0.142028939150046,0.0397229252601373,0.269956859345648
APOA2,Apolipoprotein A-II,Diet and food preferences,X20745.Liking for white wine,35359,-0.0887165288418774,0.0462945911043469,-0.179453927406397,0.00202086972264248,0.0553671208627598
APOA2,Apolipoprotein A-II,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35359,0.028052109873593,0.0474705362542901,-0.0649901411848156,0.121094360932002,0.554584136856721
APOA2,Apolipoprotein A-II,Diet and food preferences,X20747.Liking for whole milk,35359,-0.105004339319792,0.0463587272199246,-0.195867444670844,-0.0141412339687401,0.0235448763097703
APOA2,Apolipoprotein A-II,Diet and food preferences,X20748.Liking for wholemeal bread,35359,0.0243066264562441,0.0490682222671829,-0.0718670891874344,0.120480342099923,0.620360946315537
APOA2,Apolipoprotein A-II,Diet and food preferences,X20749.Liking for working up a sweat,35359,0.0523130357425096,0.0460200672988955,-0.0378862961633257,0.142512367648345,0.255689563107825
APOA2,Apolipoprotein A-II,Physical measures,X21001.Body mass index (BMI),49262,-0.196881334075246,0.0168910879913953,-0.22998786653838,-0.163774801612111,2.69993399593791e-31
APOA2,Apolipoprotein A-II,Physical measures,X21002.Weight,49277,-0.0595522444561599,0.00908623535349377,-0.0773612657490077,-0.0417432231633121,5.73316110723372e-11
APOA2,Apolipoprotein A-II,Physical measures,X21021.Pulse wave Arterial Stiffness index,36136,-0.0164349225863178,0.00608757859933543,-0.0283665766410153,-0.00450326853162041,0.00695603690327076
APOA2,Apolipoprotein A-II,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35182,0.0905779811483036,0.0497625214455307,-0.00695656088493658,0.188112523181544,0.068777759583903
APOA2,Apolipoprotein A-II,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35198,0.0370263940110322,0.0507041878562289,-0.0623538141871764,0.136406602209241,0.465269978467417
APOA2,Apolipoprotein A-II,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35200,0.0337919337366536,0.0499862942193242,-0.0641812029332219,0.131765070406529,0.499051460556235
APOA2,Apolipoprotein A-II,Health and medical history,X21040.Satisfaction with bowel habits,35156,0.0517177890484527,0.046315976535933,-0.039061524961976,0.142497103058881,0.264197809054254
APOA2,Apolipoprotein A-II,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35136,-0.0153069049601932,0.0499795500069414,-0.113266822973798,0.0826530130534119,0.759414879802855
APOA2,Apolipoprotein A-II,Health and medical history,X21042.Greatest number of times bowels opened per day,35158,-0.0510555591968274,0.0491661317113797,-0.147421177351132,0.0453100589574769,0.29911226871917
APOA2,Apolipoprotein A-II,Health and medical history,X21043.Least number of times bowels opened per week,35101,-0.0292762297681452,0.0498134455813577,-0.126910583107606,0.0683581235713159,0.556744449773654
APOA2,Apolipoprotein A-II,Health and medical history,X21044.Average number of times bowels opened per day,35127,0.0342065794687316,0.0560586881354787,-0.0756684492768066,0.14408160821427,0.541757836433256
APOA2,Apolipoprotein A-II,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35201,-0.0159551078758164,0.050341795014188,-0.114625026103625,0.082714810351992,0.751303471208464
APOA2,Apolipoprotein A-II,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35196,-0.0443567107033736,0.0507936902253949,-0.143912343545148,0.0551989221384005,0.38254974552356
APOA2,Apolipoprotein A-II,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32353,-0.0302038409220715,0.0869854576437607,-0.200695337903842,0.140287656059699,0.728442704638964
APOA2,Apolipoprotein A-II,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35200,-0.00880339486580633,0.0578082895638011,-0.122107642410857,0.104500852679244,0.878966459673079
APOA2,Apolipoprotein A-II,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35199,0.0513926819610994,0.0760872776241524,-0.0977383821822394,0.200523746104438,0.499419840951388
APOA2,Apolipoprotein A-II,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35196,0.0290227651065078,0.0580961364434983,-0.0848456623227488,0.142891192535764,0.617400101825213
APOA2,Apolipoprotein A-II,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35196,-0.143088461930822,0.144262424069,-0.425842813106063,0.139665889244419,0.32130468506373
APOA2,Apolipoprotein A-II,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35202,-0.000826152102328303,0.0594352769363778,-0.117319294897629,0.115666990692972,0.988910199806168
APOA2,Apolipoprotein A-II,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35199,-0.0675507088530934,0.0545274700591507,-0.174424550169029,0.039323132462842,0.215453880080637
APOA2,Apolipoprotein A-II,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35060,0.0689628251323638,0.052767224482128,-0.034460934852607,0.172386585117335,0.191289301872449
APOA2,Apolipoprotein A-II,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35195,0.0478148834024343,0.0504553407782517,-0.0510775845229391,0.146707351327808,0.343336949050804
APOA2,Apolipoprotein A-II,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35198,-0.088329387692251,0.0800839032965674,-0.245293838153523,0.068635062769021,0.270088502367948
APOA2,Apolipoprotein A-II,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35203,-0.0138588115012083,0.0504143375303062,-0.112670913060608,0.0849532900581918,0.783403889360061
APOA2,Apolipoprotein A-II,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35202,-0.00385643768357694,0.0503111799481363,-0.102466350381924,0.0947534750147702,0.938903178624643
APOA2,Apolipoprotein A-II,Working and living environment,X21100.Water hardness (USGS classification),49232,-0.0287488202847723,0.0261248225091075,-0.0799534724026229,0.0224558318330783,0.271153335614224
APOA2,Apolipoprotein A-II,Lifestyle factors,X2139.Age first had sexual intercourse,45961,0.00574509696079741,0.00416817379908537,-0.0024245236854099,0.0139147176070047,0.168121446927763
APOA2,Apolipoprotein A-II,Health and medical history,X2149.Lifetime number of sexual partners,44924,-0.0211255629688509,0.0298152871125859,-0.0795635257095192,0.0373123997718174,0.478615496600338
APOA2,Apolipoprotein A-II,Physical activities,X22032.IPAQ activity group,44890,0.0243326612208588,0.0297958908891053,-0.0340672849217877,0.0827326073635052,0.414143804201857
APOA2,Apolipoprotein A-II,Physical activities,X22033.Summed days activity,45328,-0.000597431122460159,0.0040913775914517,-0.00861653120170549,0.00742166895678517,0.883905848467062
APOA2,Apolipoprotein A-II,Physical activities,X22034.Summed minutes activity,44890,-0.00301082151389361,0.00406749815276313,-0.0109831178933093,0.00496147486552213,0.459180862272128
APOA2,Apolipoprotein A-II,Physical activities,X22037.MET minutes per week for walking,44045,-0.00256939156014338,0.00435368320200974,-0.0111026106360825,0.00596382751579572,0.555088996484471
APOA2,Apolipoprotein A-II,Physical activities,X22038.MET minutes per week for moderate activity,44890,0.00188155414550312,0.00395990934935863,-0.00587986817923978,0.00964297647024603,0.634686094694752
APOA2,Apolipoprotein A-II,Physical activities,X22039.MET minutes per week for vigorous activity,44890,0.0165559297980363,0.0298551514429173,-0.0419601670300815,0.0750720266261542,0.579216000078027
APOA2,Apolipoprotein A-II,Physical activities,X22040.Summed MET minutes per week for all activity,44045,-0.0002034582069242,0.00422332535762976,-0.00848117590787852,0.00807425949403012,0.961577514838907
APOA2,Apolipoprotein A-II,Eye measures,X2217.Age started wearing glasses or contact lenses,47610,-0.00988147700844711,0.00345365780265539,-0.0166506463016517,-0.00311230771524255,0.00422565517147607
APOA2,Apolipoprotein A-II,Working and living environment,X22501.Year ended full time education,33503,0.0185573493499182,0.0166342291086834,-0.0140457397031012,0.0511604384029376,0.264650367955751
APOA2,Apolipoprotein A-II,Lifestyle factors,X22506.Tobacco smoking,33480,0.10135443769835,0.121960940604921,-0.137689005887295,0.340397881283994,0.405997265175377
APOA2,Apolipoprotein A-II,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48214,-0.0577798817799134,0.0986027752679499,-0.251041321305095,0.135481557745268,0.557891631821392
APOA2,Apolipoprotein A-II,Physical measures,X23098.Weight,48856,-0.0541157953064245,0.00916648077218732,-0.0720820976199117,-0.0361494929929374,3.6136561405987e-09
APOA2,Apolipoprotein A-II,Physical measures,X23099.Body fat percentage,48848,-0.0021279265569887,0.00875657433225378,-0.0192908122482061,0.0150349591342287,0.808000945003921
APOA2,Apolipoprotein A-II,Physical measures,X23100.Whole body fat mass,48834,-0.0373913848820297,0.00862551351593725,-0.0542973913732668,-0.0204853783907927,1.46501818495032e-05
APOA2,Apolipoprotein A-II,Physical measures,X23101.Whole body fat-free mass,48855,-0.0393089575199641,0.00746178858563498,-0.0539340631478087,-0.0246838518921196,1.39345059808991e-07
APOA2,Apolipoprotein A-II,Physical measures,X23102.Whole body water mass,48856,-0.0394605556807609,0.00748411669568042,-0.0541294244042945,-0.0247916869572273,1.35945741454219e-07
APOA2,Apolipoprotein A-II,Physical measures,X23104.Body mass index (BMI),48856,-0.175487082733336,0.0168230979684996,-0.208460354751595,-0.142513810715076,2.07836051256741e-25
APOA2,Apolipoprotein A-II,Physical measures,X23105.Basal metabolic rate,48856,-0.0436100282984432,0.00796742572181264,-0.0592261827131959,-0.0279938738836904,4.46525198411043e-08
APOA2,Apolipoprotein A-II,Physical measures,X23106.Impedance of whole body,48853,0.031302245298031,0.00609871909563727,0.019348755870582,0.0432557347254801,2.88498090581317e-07
APOA2,Apolipoprotein A-II,Physical measures,X23107.Impedance of leg (right),48856,-0.00880731214644498,0.00495126676937857,-0.018511795014427,0.000897170721537012,0.0752880426383728
APOA2,Apolipoprotein A-II,Physical measures,X23108.Impedance of leg (left),48856,-0.00555741402294292,0.00491221275027997,-0.0151853510134917,0.00407052296760582,0.257923136509579
APOA2,Apolipoprotein A-II,Physical measures,X23109.Impedance of arm (right),48854,0.0549665915230785,0.00602017199566114,0.0431670544115826,0.0667661286345743,7.46892171910983e-20
APOA2,Apolipoprotein A-II,Physical measures,X23110.Impedance of arm (left),48856,0.0547743583882176,0.00603698466362267,0.0429418684475172,0.0666068483289181,1.26282603903399e-19
APOA2,Apolipoprotein A-II,Physical measures,X23111.Leg fat percentage (right),48856,-0.0366205280588994,0.0103320989828363,-0.0568714420652584,-0.0163696140525403,0.000394502365719774
APOA2,Apolipoprotein A-II,Physical measures,X23112.Leg fat mass (right),48856,-0.0725169010254103,0.0113055087274324,-0.0946756981311777,-0.0503581039196429,1.44696578209864e-10
APOA2,Apolipoprotein A-II,Physical measures,X23113.Leg fat-free mass (right),48855,-0.00868664188591744,0.00761036790495176,-0.0236029629796229,0.00622967920778802,0.253708226647625
APOA2,Apolipoprotein A-II,Physical measures,X23114.Leg predicted mass (right),48855,-0.00743402887515099,0.00765422687803995,-0.0224363135561093,0.00756825580580731,0.331444788495133
APOA2,Apolipoprotein A-II,Physical measures,X23115.Leg fat percentage (left),48853,-0.0396503880542681,0.0108382279551117,-0.0608933148462871,-0.0184074612622491,0.000254474783095745
APOA2,Apolipoprotein A-II,Physical measures,X23116.Leg fat mass (left),48853,-0.0812673837914427,0.0118224451602518,-0.104439376305536,-0.0580953912773491,6.43015858187318e-12
APOA2,Apolipoprotein A-II,Physical measures,X23117.Leg fat-free mass (left),48852,-0.0153161022969041,0.00799134047149057,-0.0309791296210256,0.0003469250272174,0.0553048553145886
APOA2,Apolipoprotein A-II,Physical measures,X23118.Leg predicted mass (left),48852,-0.0159465165006246,0.00804318853604905,-0.0317111660312808,-0.00018186696996849,0.0474247618075719
APOA2,Apolipoprotein A-II,Physical measures,X23119.Arm fat percentage (right),48852,0.020921077822546,0.00980851026916802,0.00169639769497668,0.0401457579501153,0.0329410460550742
APOA2,Apolipoprotein A-II,Physical measures,X23120.Arm fat mass (right),48850,-0.0483386113907042,0.00981764483514274,-0.067581195267584,-0.0290960275138244,8.56350270411211e-07
APOA2,Apolipoprotein A-II,Physical measures,X23121.Arm fat-free mass (right),48851,-0.0556048740137128,0.00762101577579402,-0.0705420649342691,-0.0406676830931565,3.07139020941584e-13
APOA2,Apolipoprotein A-II,Physical measures,X23122.Arm predicted mass (right),48851,-0.0545981511057877,0.00763781015367979,-0.0695682590070001,-0.0396280432045753,9.08688958200351e-13
APOA2,Apolipoprotein A-II,Physical measures,X23123.Arm fat percentage (left),48850,0.0280498046379612,0.0100704339725282,0.00831175405180586,0.0477878552241166,0.00535191653236301
APOA2,Apolipoprotein A-II,Physical measures,X23124.Arm fat mass (left),48850,-0.0426875138284768,0.00982638015484523,-0.0619472189319735,-0.0234278087249802,1.40500561412857e-05
APOA2,Apolipoprotein A-II,Physical measures,X23125.Arm fat-free mass (left),48850,-0.0605173348118689,0.00778356473431229,-0.075773121691121,-0.0452615479326168,7.91403092332372e-15
APOA2,Apolipoprotein A-II,Physical measures,X23126.Arm predicted mass (left),48848,-0.0575845997068921,0.00778798984611773,-0.0728490598052829,-0.0423201396085014,1.48162266666075e-13
APOA2,Apolipoprotein A-II,Physical measures,X23127.Trunk fat percentage,48848,0.00330035091835183,0.00625569056973609,-0.0089608025983309,0.0155615044350346,0.597799752882016
APOA2,Apolipoprotein A-II,Physical measures,X23128.Trunk fat mass,48848,-0.0192195558644168,0.00700186637724159,-0.0329432139638103,-0.00549589776502325,0.00605808088120772
APOA2,Apolipoprotein A-II,Physical measures,X23129.Trunk fat-free mass,48847,-0.0429813443052775,0.00673469172140773,-0.0561813400792367,-0.0297813485313184,1.78601818876479e-10
APOA2,Apolipoprotein A-II,Physical measures,X23130.Trunk predicted mass,48844,-0.0429705150189296,0.00676661809333828,-0.0562330864818727,-0.0297079435559866,2.19507476142413e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23400.Total Cholesterol,40532,0.00499054450977426,0.00489796418288597,-0.00460946528868224,0.0145905543082308,0.308271330863204
APOA2,Apolipoprotein A-II,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40532,-0.0260540768906947,0.00473727416051637,-0.0353391342453068,-0.0167690195360826,3.88459632137562e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40532,-0.0447763208088859,0.00471834820774824,-0.0540242832960724,-0.0355283583216993,2.77556058695825e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23403.VLDL Cholesterol,40532,-0.0654295755382188,0.00476505787784327,-0.0747690889787916,-0.056090062097646,1.44708846933776e-42
APOA2,Apolipoprotein A-II,NMR metabolomics,X23404.Clinical LDL Cholesterol,40532,-0.0109518828128686,0.00473743169423919,-0.0202372489335774,-0.00166651669215975,0.0208078415046385
APOA2,Apolipoprotein A-II,NMR metabolomics,X23405.LDL Cholesterol,40532,-0.00758067334915896,0.004757606225424,-0.01690558155099,0.00174423485267208,0.111102903916375
APOA2,Apolipoprotein A-II,NMR metabolomics,X23406.HDL Cholesterol,40532,0.105783437315812,0.00541788787616228,0.0951643770785336,0.11640249755309,1.5770180276373e-83
APOA2,Apolipoprotein A-II,NMR metabolomics,X23407.Total Triglycerides,40532,-0.0777507920673381,0.00512264737957791,-0.0877911809313109,-0.0677104032033654,1.58864053084411e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23408.Triglycerides in VLDL,40532,-0.0820741122116,0.00509331430368767,-0.0920570082468278,-0.0720912161763721,8.88551687280383e-58
APOA2,Apolipoprotein A-II,NMR metabolomics,X23409.Triglycerides in LDL,40532,-0.0454796727524875,0.00514057179806918,-0.0555551934767031,-0.0354041520282719,1.03010041452215e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23410.Triglycerides in HDL,40532,-0.0428167441271645,0.00505359972152728,-0.052721799581358,-0.0329116886729711,2.69742924745293e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40532,0.00312147954111952,0.0050843897689104,-0.00684392440594486,0.0130868834881839,0.539271285888288
APOA2,Apolipoprotein A-II,NMR metabolomics,X23412.Phospholipids in VLDL,40532,-0.0772775114141745,0.0049003336281726,-0.0868821653253928,-0.0676728575029562,1.94480713077323e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23413.Phospholipids in LDL,40532,-0.0154077928280384,0.00472934623472037,-0.0246773114480903,-0.00613827420798649,0.00112565540283302
APOA2,Apolipoprotein A-II,NMR metabolomics,X23414.Phospholipids in HDL,40532,0.0702542693797614,0.00541728807132254,0.0596363847599692,0.0808721539995535,3.44727515330618e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23415.Total Esterified Cholesterol,40532,0.0120949783430841,0.00492278690936343,0.00244631600073179,0.0217436406854364,0.0140275893258905
APOA2,Apolipoprotein A-II,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40532,-0.0595039541221371,0.00471693143505546,-0.0687491397348458,-0.0502587685094284,3.05760569726365e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40532,-0.0118338271296943,0.00476158579920757,-0.0211665352961412,-0.0025011189632475,0.0129596202449792
APOA2,Apolipoprotein A-II,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40532,0.112458995964146,0.0053740511332993,0.101925855742879,0.122992136185413,1.94064715081903e-95
APOA2,Apolipoprotein A-II,NMR metabolomics,X23419.Total Free Cholesterol,40532,-0.0125924421451251,0.00483829124791813,-0.0220754929910446,-0.00310939129920557,0.00926231918677582
APOA2,Apolipoprotein A-II,NMR metabolomics,X23420.Free Cholesterol in VLDL,40532,-0.0719554997866102,0.00485224201215627,-0.0814658941304365,-0.0624451054427839,2.73894667501849e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23421.Free Cholesterol in LDL,40532,0.00425413160840706,0.00476831585450037,-0.00509176746641367,0.0136000306832278,0.372322635545889
APOA2,Apolipoprotein A-II,NMR metabolomics,X23422.Free Cholesterol in HDL,40532,0.0760872645266027,0.00551486006114695,0.0652781388067547,0.0868963902464508,5.92218286103136e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40532,-0.0207591017754422,0.0048828236765259,-0.030329436181433,-0.0111887673694514,2.1408789623981e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23424.Total Lipids in VLDL,40532,-0.0812025473646463,0.00495778831826761,-0.0909198124684508,-0.0714852822608418,1.30821170180593e-59
APOA2,Apolipoprotein A-II,NMR metabolomics,X23425.Total Lipids in LDL,40532,-0.0122512109698331,0.0047543207736145,-0.0215696796861175,-0.00293274225354865,0.00998280539918831
APOA2,Apolipoprotein A-II,NMR metabolomics,X23426.Total Lipids in HDL,40532,0.0842934686275995,0.00543570713816345,0.0736394826367991,0.0949474546183998,1.09914602887256e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40532,0.0785107075642389,0.00512537223786917,0.0684649779780153,0.0885564371504624,1.93824330581641e-52
APOA2,Apolipoprotein A-II,NMR metabolomics,X23428.Concentration of VLDL Particles,40532,-0.0645685922541977,0.0048501892222532,-0.074074963129814,-0.0550622213785815,3.91155054578493e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23429.Concentration of LDL Particles,40532,-0.0341233011039155,0.00470220061477758,-0.0433396143088795,-0.0249069878989514,4.21992041267153e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23430.Concentration of HDL Particles,40532,0.0897382231453291,0.00511882901497338,0.0797053182759813,0.0997711280146769,6.51358866206456e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40532,-0.0762456399630945,0.0052063084350353,-0.0864500044957636,-0.0660412754304253,3.99349941932044e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23432.Average Diameter for LDL Particles,40532,0.0153039800727405,0.00499482228329402,0.00551412839748423,0.0250938317479968,0.00218934340697119
APOA2,Apolipoprotein A-II,NMR metabolomics,X23433.Average Diameter for HDL Particles,40532,0.0618046573721381,0.00561482886849011,0.0507995927898974,0.0728097219543787,4.88042420769721e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23434.Phosphoglycerides,40521,0.0151716869242949,0.00518668328501163,0.00500578768567206,0.0253375861629176,0.00345003045906598
APOA2,Apolipoprotein A-II,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40521,-0.0990409870547709,0.0053151363884292,-0.109458654376092,-0.0886233197334497,2.35633078309392e-76
APOA2,Apolipoprotein A-II,NMR metabolomics,X23436.Total Cholines,40521,0.0227055198620454,0.00519367473373176,0.0125259173839311,0.0328851223401597,1.2434612837292e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23437.Phosphatidylcholines,40521,0.022710601594433,0.0052315507186396,0.0124567621858994,0.0329644410029666,1.43012508928631e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23438.Sphingomyelins,40521,0.033665249191155,0.00508791167494925,0.0236929423082545,0.0436375560740555,3.83836439803918e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23439.Apolipoprotein B,40532,-0.0401837638848578,0.00469770842896873,-0.0493912724056365,-0.0309762553640791,1.34260332638138e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23440.Apolipoprotein A1,40532,0.0884312308730715,0.00529386679174904,0.0780552519612433,0.0988072097848996,6.6655730205479e-62
APOA2,Apolipoprotein A-II,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40532,-0.0785471261952212,0.00477227527093045,-0.0879007857262449,-0.0691934666641975,3.5938143596113e-60
APOA2,Apolipoprotein A-II,NMR metabolomics,X23442.Total Fatty Acids,40521,-0.0358605027290635,0.0050227980152137,-0.0457051868388823,-0.0260158186192446,9.93697468169634e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23443.Degree of Unsaturation,40521,0.0569557387587143,0.00503973269053367,0.0470778626852683,0.0668336148321603,1.85772651481438e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23444.Omega-3 Fatty Acids,40521,-0.0105020727140129,0.00504375131907873,-0.0203878252994072,-0.000616320128618571,0.0373470704084431
APOA2,Apolipoprotein A-II,NMR metabolomics,X23445.Omega-6 Fatty Acids,40521,-0.000960193907775423,0.00496728625798683,-0.0106960749734296,0.00877568715787877,0.846724737369232
APOA2,Apolipoprotein A-II,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40521,-0.00295377433214828,0.00503740077605455,-0.0128270798532152,0.00691953118891864,0.55763943284518
APOA2,Apolipoprotein A-II,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40521,-0.0464739039275637,0.00512692365342854,-0.0565226742882836,-0.0364251335668437,1.4547503217975e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23448.Saturated Fatty Acids,40521,-0.0490783689725834,0.00501090030566984,-0.0588997335716962,-0.0392570043734705,1.46361193809616e-22
APOA2,Apolipoprotein A-II,NMR metabolomics,X23449.Linoleic Acid,40521,-0.00406727387517811,0.00485954440755877,-0.0135919809139933,0.00545743316363708,0.402629287437
APOA2,Apolipoprotein A-II,NMR metabolomics,X23450.Docosahexaenoic Acid,40521,0.0320512635132743,0.00502538341292624,0.0222015120239389,0.0419010150026097,1.86556069130566e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40521,0.00831516355996993,0.00496253535249737,-0.00141140573092492,0.0180417328508648,0.0938465660432715
APOA2,Apolipoprotein A-II,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40521,0.0741302587953871,0.00533548147020746,0.0636727151137805,0.0845878024769938,1.57026671279521e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40521,0.0765892454417522,0.00524679686130228,0.0663055235935997,0.0868729672899046,7.93085069976782e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40521,-0.0533143856655078,0.00536079297730877,-0.063821539901033,-0.0428072314299826,3.29292496236564e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40521,-0.0682717326617354,0.00484389649471276,-0.0777657697913725,-0.0587776955320984,9.81169790535508e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40521,0.0502600279416944,0.00513890791934451,0.0401877684197791,0.0603322874636096,1.67941480614281e-22
APOA2,Apolipoprotein A-II,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40521,0.0511808041988055,0.00493118398183346,0.0415156835944119,0.0608459248031991,4.0039444627706e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40521,0.0672775709788236,0.00534251517837901,0.0568062412292008,0.0777489007284465,4.03357718934827e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40521,0.0110039215387506,0.00491927567726254,0.00136214121131606,0.0206457018661852,0.025312338411692
APOA2,Apolipoprotein A-II,NMR metabolomics,X23460.Alanine,40526,-0.00324442241346556,0.00489221993554643,-0.0128331734871366,0.00634432866020545,0.507228769045362
APOA2,Apolipoprotein A-II,NMR metabolomics,X23461.Glutamine,40490,0.0244189938809949,0.00488006680953145,0.0148540629343132,0.0339839248276765,5.70504222193057e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23462.Glycine,40517,0.0758427434557164,0.00513113773396056,0.0657857134971537,0.0858997734142791,5.56112011668661e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23463.Histidine,40513,-0.0184079171055151,0.00480666495173255,-0.0278289804109109,-0.00898685380011932,0.000129009989424462
APOA2,Apolipoprotein A-II,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40524,-0.0737468873063525,0.00504163124335586,-0.08362848454333,-0.0638652900693751,5.12753701591927e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23465.Isoleucine,40528,-0.0599618063846679,0.00492223988747481,-0.0696093965641186,-0.0503142162052173,6.32980089565765e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23466.Leucine,40528,-0.0632219802395242,0.00497426727063008,-0.0729715440899591,-0.0534724163890892,9.29069489829449e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23467.Valine,40524,-0.0793561728285165,0.00509325655240136,-0.0893389556712231,-0.0693733899858098,3.5902382792537e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23468.Phenylalanine,40525,-0.0315697198360902,0.00485095929986543,-0.0410776000638264,-0.0220618396083539,7.94063417754004e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23469.Tyrosine,40515,-0.0542311718137425,0.0049237407760968,-0.0638817037348922,-0.0445806398925927,4.53027065312305e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23470.Glucose,40507,-0.0112453415388087,0.00484334858417262,-0.020738304763787,-0.00175237831383033,0.020260764077283
APOA2,Apolipoprotein A-II,NMR metabolomics,X23471.Lactate,40509,0.000715996959539529,0.00486867549013541,-0.00882660700112587,0.0102586009202049,0.883085735081952
APOA2,Apolipoprotein A-II,NMR metabolomics,X23472.Pyruvate,40492,0.00109048070513014,0.00485212009789724,-0.00841967468674846,0.0106006360970087,0.822183166678738
APOA2,Apolipoprotein A-II,NMR metabolomics,X23473.Citrate,40530,0.0236002276582763,0.00485855654134378,0.0140774568372425,0.0331229984793101,1.20493207600075e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23474.3-Hydroxybutyrate,40344,0.0506026672809094,0.00510537581673923,0.0405961306801005,0.0606092038817183,4.61438481637386e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23475.Acetate,40520,3.59332573299266e-05,0.00479374380564047,-0.0093598046017254,0.00943167111638525,0.994019352919709
APOA2,Apolipoprotein A-II,NMR metabolomics,X23476.Acetoacetate,40530,-0.010226663133113,0.00492717581273785,-0.0198839277260792,-0.000569398540146775,0.0379568922247987
APOA2,Apolipoprotein A-II,NMR metabolomics,X23477.Acetone,40530,0.0120296717947937,0.00487708796019247,0.00247057939281647,0.0215887641967709,0.0136561425101742
APOA2,Apolipoprotein A-II,NMR metabolomics,X23478.Creatinine,40263,0.070519045182369,0.00563697232093143,0.0594705794333434,0.0815675109313946,1.14531678045928e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23479.Albumin,40529,0.0133549783454641,0.00487406240809204,0.0038018160256037,0.0229081406653245,0.00615335099797474
APOA2,Apolipoprotein A-II,NMR metabolomics,X23480.Glycoprotein Acetyls,40532,-0.00306455192908878,0.00520068462979078,-0.0132578938034787,0.00712878994530114,0.555699064623153
APOA2,Apolipoprotein A-II,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40532,-0.0961391029750917,0.00512402393300934,-0.10618218988379,-0.0860960160663934,2.26328409711536e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40532,-0.0970822182050559,0.00505499647999905,-0.106990011305854,-0.0871744251042578,6.41127099317494e-81
APOA2,Apolipoprotein A-II,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40532,-0.09293147650928,0.0051428655722276,-0.103011493030846,-0.0828514599877139,5.59488422624641e-72
APOA2,Apolipoprotein A-II,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40532,-0.0914488579565677,0.00508708872175922,-0.101419551851216,-0.0814781640619197,2.88457092818053e-71
APOA2,Apolipoprotein A-II,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40532,-0.0917424062411859,0.00502003764792091,-0.101581680031111,-0.0819031324512609,1.47541981166177e-73
APOA2,Apolipoprotein A-II,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40532,-0.0892907255125886,0.00514324699904225,-0.0993714896307114,-0.0792099613944658,1.18583604799709e-66
APOA2,Apolipoprotein A-II,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40532,-0.0986844124938701,0.00500556032712748,-0.10849531073504,-0.0888735142527002,4.23728209557339e-85
APOA2,Apolipoprotein A-II,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40532,-0.0899506191781591,0.00510751754395374,-0.0999613535643084,-0.0799398847920098,1.63887849570748e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40532,-0.0925718825115647,0.00507565577187035,-0.102520167824431,-0.0826235971986988,2.84102232899441e-73
APOA2,Apolipoprotein A-II,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40532,-0.0949495107969952,0.00506190704715753,-0.104870848609424,-0.0850281729845664,2.46895340117962e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40532,-0.0871407591053028,0.00495578020922275,-0.0968540883153794,-0.0774274298952262,2.64053607622953e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40532,-0.0784598279761219,0.00488817006297184,-0.0880406412995467,-0.0688790146526971,2.40664076531535e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40532,-0.0940067504512814,0.00502591505131719,-0.103857543951863,-0.0841559569506997,6.51457697167704e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40532,-0.0906539909728381,0.00510683164460056,-0.100663380996255,-0.080644600949421,1.45978553277633e-69
APOA2,Apolipoprotein A-II,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40532,-0.0824780879317523,0.00505600546409499,-0.0923878586413785,-0.0725683172221261,3.76139587744708e-59
APOA2,Apolipoprotein A-II,NMR metabolomics,X23496.Total Lipids in Large VLDL,40532,-0.0822437079217555,0.00502498733232324,-0.0920926830931091,-0.072394732750402,1.58198628650488e-59
APOA2,Apolipoprotein A-II,NMR metabolomics,X23497.Phospholipids in Large VLDL,40532,-0.0842725110377619,0.00505024537496942,-0.0941709919727019,-0.0743740301028218,8.89635553803552e-62
APOA2,Apolipoprotein A-II,NMR metabolomics,X23498.Cholesterol in Large VLDL,40532,-0.0771597127048574,0.00496117415086973,-0.0868836140405621,-0.0674358113691528,5.49939670104624e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40532,-0.0697249248959624,0.00488509506332319,-0.0792997112200759,-0.060150138571849,8.03578129693474e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40532,-0.082820080920059,0.00504144751704672,-0.0927013180534705,-0.0729388437866474,5.94392485160363e-60
APOA2,Apolipoprotein A-II,NMR metabolomics,X23501.Triglycerides in Large VLDL,40532,-0.0805828201688634,0.00501565624051497,-0.0904135064002727,-0.070752133937454,1.89107843231834e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40532,-0.0525479765133764,0.00478096047763132,-0.0619186590495338,-0.043177293977219,5.83653870929433e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40532,-0.0578386856243897,0.00482457837722824,-0.067294859243757,-0.0483825120050223,6.46567741956861e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40532,-0.0524326566498624,0.00476189897857768,-0.0617659786478746,-0.0430993346518501,4.69779996739236e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40532,-0.0303517345242462,0.00469977390808671,-0.0395632913840961,-0.0211401776643962,1.10342082109787e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40532,-0.0171474578514961,0.00472291406177483,-0.0264043694125747,-0.00789054629041738,0.000283904964037797
APOA2,Apolipoprotein A-II,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40532,-0.0454153994576189,0.00473682549714403,-0.0546995774320212,-0.0361312214832166,1.0881501560967e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40532,-0.0654763904342189,0.00499340967177995,-0.0752634733909076,-0.0556893074775302,5.35986171387576e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40532,-0.0521777147583247,0.00493446873397115,-0.0618492734769082,-0.0425061560397413,5.19084548298e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23510.Total Lipids in Small VLDL,40532,-0.0529040661110334,0.00491931165653228,-0.0625459169578366,-0.0432622152642301,7.6146114016851e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23511.Phospholipids in Small VLDL,40532,-0.0450861904096401,0.00481451105606416,-0.0545226320795258,-0.0356497487397543,9.06757743526684e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23512.Cholesterol in Small VLDL,40532,-0.0454162704838518,0.0047673394966046,-0.0547602558971969,-0.0360722850705068,1.95575388335351e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40532,-0.0498835964650683,0.00478569395015834,-0.0592635566073786,-0.0405036363227579,2.5210281772442e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40532,-0.0364381386933591,0.00474108658904572,-0.0457306684078887,-0.0271456089788295,1.6482855894411e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23515.Triglycerides in Small VLDL,40532,-0.0514896260726933,0.00510776532833088,-0.0615008461162218,-0.0414784060291648,8.47394259635389e-24
APOA2,Apolipoprotein A-II,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40532,-0.0587176688719824,0.00480476768213295,-0.068135013528963,-0.0493003242150018,3.94939179350123e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40532,-0.0616252934314442,0.00484639948976501,-0.0711242364313836,-0.0521263504315048,8.62515953322138e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40532,-0.0673485790368273,0.00483996625489024,-0.0768349128964122,-0.0578622451772425,1.17145242741452e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40532,-0.0507572238371936,0.00479840027280622,-0.0601620883718938,-0.0413523593024934,4.98569470631844e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40532,-0.0473875488510081,0.00480925409863656,-0.0568136868843357,-0.0379614108176804,8.18152033241813e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40532,-0.0574587884605972,0.00481261969785742,-0.0668915230683978,-0.0480260538527967,1.16020108808741e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40532,-0.0528190261439284,0.00510891198876642,-0.0628324936419105,-0.0428055586459462,6.08261112441863e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23523.Concentration of IDL Particles,40532,-0.0430928805503808,0.00467953561351139,-0.0522647703528631,-0.0339209907478985,3.87610137005309e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23524.Total Lipids in IDL,40532,-0.0216098234588702,0.00483649085657185,-0.031089345537751,-0.0121303013799894,7.96897892915897e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23525.Phospholipids in IDL,40532,-0.0248341977348517,0.00484309706815835,-0.0343266679884421,-0.0153417274812613,2.98060557854794e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23526.Cholesterol in IDL,40532,-0.0149914714366008,0.0048373883087237,-0.0244727525216993,-0.00551019035150234,0.00194595266630471
APOA2,Apolipoprotein A-II,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40532,-0.0164931965206944,0.0048420618641803,-0.0259836377744878,-0.00700275526690103,0.00066094275009046
APOA2,Apolipoprotein A-II,NMR metabolomics,X23528.Free Cholesterol in IDL,40532,-0.0106568069346293,0.00481891205941222,-0.0201018745710773,-0.00121173929818139,0.0270242206445667
APOA2,Apolipoprotein A-II,NMR metabolomics,X23529.Triglycerides in IDL,40532,-0.0529973741321547,0.00511745532950282,-0.0630275865779802,-0.0429671616863292,5.07060810414261e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23530.Concentration of Large LDL Particles,40532,-0.0312702283189748,0.00470495807663303,-0.0404919461491755,-0.022048510488774,3.14486883352107e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23531.Total Lipids in Large LDL,40532,-0.00483711712116399,0.00478572381075268,-0.0142171357902392,0.00454290154791126,0.312162992459299
APOA2,Apolipoprotein A-II,NMR metabolomics,X23532.Phospholipids in Large LDL,40532,-0.00941393608381959,0.00475304541893238,-0.0187299051049271,-9.79670627121211e-05,0.0476589953818576
APOA2,Apolipoprotein A-II,NMR metabolomics,X23533.Cholesterol in Large LDL,40532,0.000134216192378203,0.00479468300413201,-0.00926336249572054,0.00953179488047695,0.977668454538046
APOA2,Apolipoprotein A-II,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40532,-0.00177257985594373,0.0047927443327076,-0.0111663587480506,0.00762119903616315,0.711503752093528
APOA2,Apolipoprotein A-II,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40532,0.0055365009805324,0.00480599055015262,-0.00388324049776673,0.0149562424588315,0.24934537456129
APOA2,Apolipoprotein A-II,NMR metabolomics,X23536.Triglycerides in Large LDL,40532,-0.0428003021961593,0.00513135293663094,-0.052857753951956,-0.0327428504403627,8.22176770336946e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40532,-0.0339858763452133,0.0047281064290863,-0.0432529649462225,-0.0247187877442042,6.9851731638904e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23538.Total Lipids in Medium LDL,40532,-0.021112295259583,0.00476154016771015,-0.0304449139882949,-0.0117796765308711,9.340481420519e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23539.Phospholipids in Medium LDL,40532,-0.019359312911868,0.00474919161699091,-0.0286677284811702,-0.0100508973425659,4.60625431922351e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23540.Cholesterol in Medium LDL,40532,-0.0189843701790532,0.00475222041874814,-0.0282987221997996,-0.00967001815830686,6.51464638530564e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40532,-0.0272000628402187,0.00477314132685111,-0.0365554198408469,-0.0178447058395905,1.23830599560736e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40532,0.00373456958331107,0.00474247248599961,-0.00556067648924817,0.0130298156558703,0.431021421557588
APOA2,Apolipoprotein A-II,NMR metabolomics,X23543.Triglycerides in Medium LDL,40532,-0.0409319777334692,0.00515305247187285,-0.05103196057834,-0.0308319948885984,2.1554679301701e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23544.Concentration of Small LDL Particles,40532,-0.0419235765578999,0.00469385433345326,-0.0511235310514683,-0.0327236220643315,4.84563264854192e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23545.Total Lipids in Small LDL,40532,-0.0311439509965995,0.00470812060035344,-0.0403718673732923,-0.0219160346199068,3.88420773967198e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23546.Phospholipids in Small LDL,40532,-0.0298193063051093,0.00467205274437286,-0.0389765296840801,-0.0206620829261384,1.81035799733162e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23547.Cholesterol in Small LDL,40532,-0.025609357150368,0.0047098842194946,-0.0348407302205774,-0.0163779840801586,5.51957813381471e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40532,-0.0340234017103243,0.00473574729151381,-0.0433054664016913,-0.0247413370189572,7.17469764047288e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40532,-0.00185593341660732,0.0047040657657605,-0.0110759023174979,0.00736403548428326,0.693191185969007
APOA2,Apolipoprotein A-II,NMR metabolomics,X23550.Triglycerides in Small LDL,40532,-0.0617382892559737,0.00515128554897144,-0.0718348089319577,-0.0516417695799897,6.72618183477101e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40532,0.0295240239538582,0.00539178729624006,0.0189561208532277,0.0400919270544887,4.44974566375517e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40532,0.0250316556155412,0.00541613758135617,0.0144160259560831,0.0356472852749993,3.84844227703636e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40532,0.0224551984706721,0.00544818518041856,0.0117767555170517,0.0331336414242925,3.78939887529453e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40532,0.0334155451862327,0.00535857022041936,0.0229127475542107,0.0439183428182546,4.65148928599586e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40532,0.0458641678384045,0.00540953325146413,0.0352614826655348,0.0564668530112742,2.56553880124415e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40532,-0.00728848982088093,0.0051259860786673,-0.0173354225350688,0.00275844289330698,0.155091274084841
APOA2,Apolipoprotein A-II,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40532,-0.0300756078101214,0.00505307906604193,-0.0399796427795636,-0.0201715728406792,2.72827265057195e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23558.Concentration of Large HDL Particles,40532,0.0871115885444414,0.00560940742692067,0.0761171499876769,0.0981060271012059,7.83420140710343e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23559.Total Lipids in Large HDL,40532,0.0810948373999015,0.0056278475464497,0.0700642562088601,0.0921254185909429,1.16288896859e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23560.Phospholipids in Large HDL,40532,0.0762154230403236,0.00563067980918522,0.0651792906143206,0.0872515554663267,2.01702423476172e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23561.Cholesterol in Large HDL,40532,0.0865813513887926,0.00555970338412537,0.0756843327559068,0.0974783700216783,4.03089140405455e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40532,0.0932488099419593,0.00553788280944312,0.0823945596354508,0.104103060248468,7.39481875830054e-63
APOA2,Apolipoprotein A-II,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40532,0.0627904744272408,0.00559720505580657,0.0518199525178599,0.0737609963366217,4.72172902871251e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23564.Triglycerides in Large HDL,40532,-0.000397200771536002,0.00521260182967664,-0.0106139003577022,0.00981949881463021,0.939261248989695
APOA2,Apolipoprotein A-II,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40532,0.0878623042062286,0.00524582261111001,0.077580491888453,0.0981441165240042,3.21356487328222e-62
APOA2,Apolipoprotein A-II,NMR metabolomics,X23566.Total Lipids in Medium HDL,40532,0.0763061159979223,0.00521481494840727,0.0660850786990441,0.0865271532968006,4.76875809142235e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23567.Phospholipids in Medium HDL,40532,0.0598189910554093,0.00520184428541128,0.0496233762560032,0.0700146058548154,1.95488307820614e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23568.Cholesterol in Medium HDL,40532,0.100395427703857,0.00521615088244949,0.0901717719742555,0.110619083433458,2.93606557973483e-81
APOA2,Apolipoprotein A-II,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40532,0.10374579498806,0.0051806683085965,0.0935916851032111,0.113899904872909,1.07249203276202e-87
APOA2,Apolipoprotein A-II,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40532,0.0827607798133539,0.00533912172885528,0.0722961012247976,0.0932254584019103,1.21433367608863e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23571.Triglycerides in Medium HDL,40532,-0.0474078245452444,0.00502245179408241,-0.0572518300616459,-0.0375638190288429,4.48917587258423e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23572.Concentration of Small HDL Particles,40532,0.0522907221904183,0.00482427697292221,0.0428351393234908,0.0617463050573458,3.05593101915688e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23573.Total Lipids in Small HDL,40532,0.0332168703440768,0.00487659841558655,0.0236587374495271,0.0427750032386264,1.01484823531943e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23574.Phospholipids in Small HDL,40532,0.0265950096574993,0.00491089403708945,0.016969657344804,0.0362203619701947,6.23607767957253e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23575.Cholesterol in Small HDL,40532,0.0615867808499778,0.00481393092175412,0.0521514762433397,0.0710220854566159,3.22501339581354e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40532,0.0644242976643922,0.00477950159734132,0.0550564745336032,0.0737921207951812,4.28920042204035e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40532,0.0457344013408478,0.00496161007151297,0.0360096456006823,0.0554591570810132,3.57113321568812e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23578.Triglycerides in Small HDL,40532,-0.0623782313942056,0.0051035167358236,-0.0723811241964198,-0.0523753385919913,3.85986609403761e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,40102,0.0445845136502788,0.0049056439777618,0.0349694514538657,0.0541995758466919,1.17854676188905e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,40102,0.0586547461539215,0.00503605265962997,0.0487840829410468,0.0685254093667963,3.63481781344576e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,40102,0.0366952539757545,0.00499459062447847,0.0269058563517767,0.0464846515997323,2.1718793072229e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,40102,0.0832310357103114,0.00503113428924625,0.0733700125033887,0.093092058917234,9.82028794054749e-61
APOA2,Apolipoprotein A-II,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,40102,-0.0588068855399794,0.00499648102557903,-0.0685999883501143,-0.0490137827298445,8.70810338647267e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40432,-0.054437667756978,0.00487276550938083,-0.0639882881553644,-0.0448870473585916,7.94557382512471e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40432,0.0465405553573543,0.00511735171329716,0.0365105459992919,0.0565705647154168,1.10805205806661e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40432,0.0535217511547278,0.00512571541193596,0.0434753489473333,0.0635681533621223,2.08737078450758e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40432,0.0115002037973205,0.00506112459210304,0.00158039959679854,0.0214200079978424,0.023089465916162
APOA2,Apolipoprotein A-II,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40432,-0.0241008033229805,0.00503895901909149,-0.0339771630003998,-0.0142244436455611,1.74985372862603e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40531,-0.0615212218943239,0.00501020844247157,-0.0713412304415682,-0.0517012133470796,1.93889982984398e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40531,0.021437500527734,0.00488056420388752,0.0118715946881144,0.0310034063673535,1.1311176853287e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40531,0.0331742078920723,0.00501046226010969,0.0233537018622573,0.0429947139218873,3.72924105189106e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40531,-0.00841225929613234,0.00482132227544942,-0.0178620509560132,0.00103753236374851,0.0810462002035839
APOA2,Apolipoprotein A-II,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40531,0.00742331905134097,0.00480548645451645,-0.00199543439951128,0.0168420725021932,0.12243244918732
APOA2,Apolipoprotein A-II,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40532,-0.00173706672374272,0.00489680310922764,-0.0113348008178289,0.00786066737034346,0.722794836704982
APOA2,Apolipoprotein A-II,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40532,0.0293003941692744,0.00507450224077934,0.0193543697773469,0.0392464185612019,7.94231951411071e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40532,0.0339677508597551,0.00512372620001023,0.0239252475077351,0.0440102542117752,3.52113422655537e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40532,0.0161687799560667,0.00495607953206887,0.0064548640732117,0.0258826958389217,0.001107946579635
APOA2,Apolipoprotein A-II,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40532,-0.0224080133975026,0.00503184749373852,-0.0322704344852301,-0.0125455923097751,8.53940708536602e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40532,0.0187401173131257,0.00507230181020393,0.00879840576512597,0.0286818288611254,0.000221270737301325
APOA2,Apolipoprotein A-II,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40532,-0.00249616404899768,0.00494877552722281,-0.0121957640823544,0.00720343598435903,0.613989882406108
APOA2,Apolipoprotein A-II,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40532,-0.0179240835552519,0.00484950194611856,-0.0274291073696443,-0.00841905974085951,0.000219996876139153
APOA2,Apolipoprotein A-II,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40532,0.0199420364560857,0.00509134702401697,0.0099629962890124,0.0299210766231589,9.02400663958275e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40532,-0.00392591375893777,0.00499191743017033,-0.0137100719220716,0.00585824440419607,0.431617956388491
APOA2,Apolipoprotein A-II,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40532,-0.0563074682355356,0.00492238229708639,-0.065955337537825,-0.0466595989332463,3.90189010505584e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40532,0.00765766611809662,0.00513265606993164,-0.00240233977896938,0.0177176720151626,0.135740081127374
APOA2,Apolipoprotein A-II,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40532,0.00885855125750977,0.00517362532026771,-0.00128175437021494,0.0189988568852345,0.0868775486630402
APOA2,Apolipoprotein A-II,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40532,-0.00489601324676688,0.0048703143767757,-0.0144418294252473,0.0046498029317135,0.31478511614246
APOA2,Apolipoprotein A-II,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40532,0.00596974156840237,0.00511356976050423,-0.00405285516218592,0.0159923382989907,0.243060773723693
APOA2,Apolipoprotein A-II,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40532,-0.0104778821934436,0.00467495593013054,-0.0196407958164995,-0.00131496857038777,0.0250272573388527
APOA2,Apolipoprotein A-II,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40532,0.0227703774242338,0.00495489065250901,0.0130587917453161,0.0324819631031515,4.36298034625847e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40532,0.0103971178619703,0.00495836538610878,0.000678721705197094,0.0201155140187435,0.0360259265702886
APOA2,Apolipoprotein A-II,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40532,0.0363690794392973,0.0047383817195865,0.0270818512689078,0.0456563076096868,1.7839880908407e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40532,-0.0248936521398767,0.00511150452280704,-0.0349122010045785,-0.0148751032751749,1.13035468053822e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40532,-0.032766018209045,0.00473099101764814,-0.0420387606036353,-0.0234932758144546,4.5688730749984e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40532,0.059903809940916,0.00510796438343035,0.0498921997493925,0.0699154201324395,1.4014809900987e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40532,0.0341023122892415,0.00475112132101437,0.0247901145000534,0.0434145100784297,7.5300877791675e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40532,0.0385022193939401,0.00511625498753679,0.028474359618368,0.0485300791695122,5.65071060245411e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40532,-0.0357330085157561,0.00511693242659837,-0.0457621960718889,-0.0257038209596233,3.04477540491769e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40532,0.020798410611818,0.0048435388686309,0.0113050744293014,0.0302917467943346,1.76900609746614e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40532,0.00865841442188319,0.00473105540281037,-0.000614454167625129,0.0179312830113915,0.0672577524248127
APOA2,Apolipoprotein A-II,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40532,-0.0611959689502548,0.00485374851063099,-0.0707093160310915,-0.0516826218694181,3.33712313478788e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40532,0.0791453542979773,0.00517988947944238,0.0689927709182702,0.0892979376776843,3.47048193998599e-52
APOA2,Apolipoprotein A-II,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40532,-0.0180892355442979,0.00503455146226484,-0.027956956410337,-0.00822151467825879,0.000328254457927762
APOA2,Apolipoprotein A-II,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40532,0.0132171933309385,0.00479409930510997,0.00382075869292294,0.022613627968954,0.00584328226007412
APOA2,Apolipoprotein A-II,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40532,0.0246657433961478,0.00482514604141409,0.0152084571549762,0.0341230296373194,3.24104929534086e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40532,-0.0323477429173337,0.00479503012191299,-0.0417460019562832,-0.0229494838783843,1.59267073263116e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40532,0.0624316475417078,0.0050950505041301,0.0524453485536128,0.0724179465298027,2.65446067122985e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40532,-0.039298974689154,0.00511638723851629,-0.0493270936766459,-0.029270855701662,1.70836642200768e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40523,0.00537477310923709,0.00532589359076019,-0.00506397832865289,0.0158135245471271,0.312910966695147
APOA2,Apolipoprotein A-II,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40523,0.0285817287786025,0.00503669975445174,0.018709797259877,0.0384536602973279,1.42346166762969e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40523,0.0880434764180052,0.00483596802284499,0.0785649790932291,0.0975219737427814,5.06356144143956e-73
APOA2,Apolipoprotein A-II,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40523,-0.0805876618722622,0.00554841521766159,-0.0914625556988789,-0.0697127680456454,2.25843299412117e-47
APOA2,Apolipoprotein A-II,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40523,-0.0425473471591826,0.00530205427519719,-0.0529393735385691,-0.0321553207797961,1.11810916744587e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40532,-0.0724142597665106,0.00514681808269296,-0.0825020232085888,-0.0623264963244324,1.38164719117018e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40532,0.0835061110573993,0.00531112782753348,0.0730963005154336,0.0939159215993649,4.02338190106948e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40532,0.101414586820802,0.00531519967426024,0.0909967954592523,0.111832378182352,6.56254692084334e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40532,-0.0317196700204637,0.00508176798857499,-0.0416799352780706,-0.0217594047628567,4.47848465834957e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40532,-0.0684989006142824,0.00527894561967168,-0.0788456340288389,-0.0581521671997259,3.13695656983129e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40532,-0.151971707533197,0.00507991742513908,-0.16192834568647,-0.142015069379925,2.4504796563857e-189
APOA2,Apolipoprotein A-II,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40532,0.123146250017695,0.00509828831682653,0.113153604916715,0.133138895118675,9.76027191716734e-126
APOA2,Apolipoprotein A-II,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40532,0.119802689382716,0.0050640612602487,0.109877129312629,0.129728249452803,8.13448670428368e-121
APOA2,Apolipoprotein A-II,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40532,0.077661448369451,0.00546794669323024,0.0669442728507197,0.0883786238881823,2.14820254806791e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40532,-0.0947281906246203,0.00507679064709302,-0.104678700292923,-0.084777680956318,1.4850476268384e-76
APOA2,Apolipoprotein A-II,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40532,-0.0406598722621617,0.00501628064285088,-0.0504917823221494,-0.030827962202174,5.78802828025942e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40532,0.0852165700198201,0.00496120521328611,0.0754926078017794,0.0949405322378609,2.65719271192832e-65
APOA2,Apolipoprotein A-II,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40532,0.0765455854875872,0.00502438064442534,0.0666977994245135,0.0863933715506608,6.77159275692509e-52
APOA2,Apolipoprotein A-II,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40532,0.0318649255581246,0.00502835131913743,0.0220093569726152,0.0417204941436339,2.43084911134814e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40532,-0.091554112860836,0.00513265821994803,-0.101614122971934,-0.0814941027497379,3.27591221651892e-70
APOA2,Apolipoprotein A-II,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,49103,-0.00152028998628744,0.00414354682284075,-0.00964164175905532,0.00660106178648043,0.713693432017043
APOA2,Apolipoprotein A-II,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,49103,0.000693006840032021,0.00404174116110032,-0.0072288058357246,0.00861481951578864,0.863861896652327
APOA2,Apolipoprotein A-II,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47750,0.0044407862895368,0.00384606209448044,-0.00309749541564487,0.0119790679947185,0.248256034182987
APOA2,Apolipoprotein A-II,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47750,0.00210541830105461,0.00424276509172931,-0.00621040127873485,0.0104212378808441,0.619732873983426
APOA2,Apolipoprotein A-II,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47750,-0.000501682129663685,0.00411018197777961,-0.00855763880611171,0.00755427454678434,0.902854109679408
APOA2,Apolipoprotein A-II,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47750,0.000234602487392713,0.00377259159121216,-0.00715967703138311,0.00762888200616854,0.950415358534165
APOA2,Apolipoprotein A-II,Working and living environment,X24009.Traffic intensity on the nearest road,49103,-0.00705092042870981,0.0575749234342702,-0.119897770359879,0.10579592950246,0.902531897210259
APOA2,Apolipoprotein A-II,Working and living environment,X24010.Inverse distance to the nearest road,49103,0.00138415438810546,0.00364032020854109,-0.00575087322063508,0.008519181996846,0.703779678796314
APOA2,Apolipoprotein A-II,Working and living environment,X24011.Traffic intensity on the nearest major road,49103,-0.0035532194773344,0.00357438957683937,-0.0105590230479396,0.00345258409327077,0.320197325755953
APOA2,Apolipoprotein A-II,Working and living environment,X24012.Inverse distance to the nearest major road,49103,0.000617305334427192,0.0036717545135399,-0.00657933351211101,0.0078139441809654,0.866488448132186
APOA2,Apolipoprotein A-II,Working and living environment,X24013.Total traffic load on major roads,49103,0.0285820773855519,0.0404291374052686,-0.0506590319287747,0.107823186699878,0.479595084963581
APOA2,Apolipoprotein A-II,Working and living environment,X24015.Sum of road length of major roads within 100m,49103,0.0194194333406259,0.0392326123485,-0.057476486862434,0.0963153535436858,0.62061835368776
APOA2,Apolipoprotein A-II,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,49103,0.00365027918196336,0.00412839938731401,-0.00444138361717211,0.0117419419810988,0.376605675927457
APOA2,Apolipoprotein A-II,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,49103,0.00271057992449645,0.00411908169592861,-0.00536282019952362,0.0107839800485165,0.510510770378433
APOA2,Apolipoprotein A-II,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,49103,0.00285812615439036,0.00407323213935814,-0.00512540883875159,0.0108416611475323,0.482883791767205
APOA2,Apolipoprotein A-II,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,49053,-0.000401399585033871,0.00405336561992152,-0.00834599620008005,0.00754319703001231,0.921116471131581
APOA2,Apolipoprotein A-II,Working and living environment,X24020.Average daytime sound level of noise pollution,49103,-0.00447712539099466,0.00364557966673634,-0.0116224615377979,0.00266821075580857,0.219425081707224
APOA2,Apolipoprotein A-II,Working and living environment,X24021.Average evening sound level of noise pollution,49103,-0.00446573655931993,0.00364669754977006,-0.0116132637568692,0.00268179063822939,0.220741414629182
APOA2,Apolipoprotein A-II,Working and living environment,X24022.Average night-time sound level of noise pollution,49103,-0.00447458107756514,0.00364539858448569,-0.0116195623031571,0.00267040014802681,0.219664246708324
APOA2,Apolipoprotein A-II,Working and living environment,X24023.Average 16-hour sound level of noise pollution,49103,-0.00442868247943989,0.00364608989655504,-0.0115750186766878,0.00271765371780798,0.224518266255075
APOA2,Apolipoprotein A-II,Working and living environment,X24024.Average 24-hour sound level of noise pollution,49103,-0.00443368628901382,0.00364609006482735,-0.0115800228160754,0.00271265023804779,0.223995079981677
APOA2,Apolipoprotein A-II,Health and medical history,X2405.Number of children fathered,38617,-0.125422544735446,0.0452154780924283,-0.214044881796606,-0.036800207674287,0.00555002161372851
APOA2,Apolipoprotein A-II,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46970,0.00295215411920298,0.00421396796831137,-0.0053072230986873,0.0112115313370933,0.483584340986876
APOA2,Apolipoprotein A-II,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46970,-0.00187222447977396,0.00378763980762755,-0.00929599850272396,0.00555154954317605,0.621101528986588
APOA2,Apolipoprotein A-II,Working and living environment,"X24502.Water percentage, buffer 1000m",46970,-0.00292716832670853,0.00384096556339405,-0.0104554608309609,0.00460112417754381,0.446015332979419
APOA2,Apolipoprotein A-II,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46970,0.0021231997936411,0.00393561402542586,-0.00559060369619358,0.00983700328347578,0.589559867148465
APOA2,Apolipoprotein A-II,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46970,-0.00233985563266612,0.00380080919485098,-0.00978944165457405,0.0051097303892418,0.538152973464684
APOA2,Apolipoprotein A-II,Working and living environment,"X24505.Water percentage, buffer 300m",46970,0.00031675100001182,0.0038853611408895,-0.0072985568361316,0.00793205883615524,0.935025989494409
APOA2,Apolipoprotein A-II,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",49232,0.00351939654528771,0.00405226277174845,-0.00442303848733925,0.0114618315779147,0.385130219409497
APOA2,Apolipoprotein A-II,Working and living environment,"X24507.Natural environment percentage, buffer 300m",49232,0.000183597175169327,0.00380087687194737,-0.00726612149384752,0.00763331584418617,0.961474528082924
APOA2,Apolipoprotein A-II,Working and living environment,X24508.Distance (Euclidean) to coast,49232,0.00322122229604403,0.0035752575665713,-0.00378628253443571,0.0102287271265238,0.367611754910044
APOA2,Apolipoprotein A-II,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34755,0.0436226759130069,0.0529139591912183,-0.0600886841017809,0.147334035927795,0.409743293544021
APOA2,Apolipoprotein A-II,Health and medical history,X2704.Years since last cervical smear test,37331,0.0243030584548504,0.0459714890658593,-0.0658010601142339,0.114407177023935,0.597059204154111
APOA2,Apolipoprotein A-II,Health and medical history,X2714.Age when periods started (menarche),39440,-0.000663154727811043,0.0367512070529794,-0.0726955205516507,0.0713692110960286,0.985603757361112
APOA2,Apolipoprotein A-II,Health and medical history,X2734.Number of live births,39757,-0.0521033181477635,0.0358528936436588,-0.122374989689335,0.0181683533938077,0.146183302911342
APOA2,Apolipoprotein A-II,Health and medical history,X2744.Birth weight of first child,38164,-0.0372584448042392,0.0385204806773286,-0.112758586931803,0.0382416973233249,0.333451532091255
APOA2,Apolipoprotein A-II,Health and medical history,X2754.Age at first live birth,37074,-0.00176566699431756,0.00646592673917928,-0.0144388834031089,0.0109075494144738,0.784804614937543
APOA2,Apolipoprotein A-II,Health and medical history,X2764.Age at last live birth,37049,-0.00509934726167744,0.00590209790923002,-0.0166674591637683,0.00646876464041339,0.387620349362018
APOA2,Apolipoprotein A-II,Health and medical history,X2794.Age started oral contraceptive pill,36116,0.0036941999515215,0.00925722188465826,-0.0144499549424087,0.0218383548454517,0.689860269817739
APOA2,Apolipoprotein A-II,Health and medical history,X2804.Age when last used oral contraceptive pill,35443,-0.00240591837075113,0.00698308447162097,-0.0160927639351282,0.011280927193626,0.730455424590989
APOA2,Apolipoprotein A-II,Lifestyle factors,X2867.Age started smoking in former smokers,35348,-0.00168446764260419,0.00710173141056377,-0.0156038612073092,0.0122349259221008,0.812516417278661
APOA2,Apolipoprotein A-II,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35199,0.130656611008699,0.0633344583408789,0.00652107266057671,0.254792149356822,0.0391591026709135
APOA2,Apolipoprotein A-II,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35198,0.106364838656986,0.0688500241163972,-0.0285812086111528,0.241310885925124,0.122428668398127
APOA2,Apolipoprotein A-II,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35209,0.00735719882141618,0.0717387919718739,-0.133250833443457,0.147965231086289,0.918319280184866
APOA2,Apolipoprotein A-II,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35185,0.0887583280593302,0.0702441109014946,-0.0489201293075993,0.22643678542626,0.206433708163329
APOA2,Apolipoprotein A-II,Mental health,X28739.Difficulty with standing for long periods,35211,0.089508805613139,0.0540739225432196,-0.0164760825715714,0.195493693797849,0.0979149292904116
APOA2,Apolipoprotein A-II,Mental health,X28740.Difficulty with taking care of household responsibilities,35233,0.0186400718181186,0.0593673019909675,-0.0977198400841777,0.134999983720415,0.753548021708141
APOA2,Apolipoprotein A-II,Mental health,X28741.Difficulty learning a new task,35177,0.12859784577526,0.0690005611177012,-0.0066432540154347,0.263838945565954,0.0624097648908901
APOA2,Apolipoprotein A-II,Mental health,X28742.Difficulty with joining in community activities,34951,0.127978171019735,0.0733142959582799,-0.0157178490584931,0.271674191097964,0.0809321103461006
APOA2,Apolipoprotein A-II,Mental health,X28743.Difficulty with being emotionally affected by health problems,35201,0.0432504517452777,0.0617698759740144,-0.0778185051637906,0.164319408654346,0.483837784087776
APOA2,Apolipoprotein A-II,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35234,0.153962312992758,0.0933201547798091,-0.0289451903756678,0.336869816361184,0.0990299054313393
APOA2,Apolipoprotein A-II,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34943,0.0580334143738619,0.0495674818059876,-0.0391188499658738,0.155185678713598,0.241729272477616
APOA2,Apolipoprotein A-II,Lifestyle factors,X2897.Age stopped smoking,35343,0.00313459150647776,0.00667978175155229,-0.00995778072656472,0.0162269637395202,0.638896466397145
APOA2,Apolipoprotein A-II,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34603,0.0172261067184604,0.0149863423311498,-0.0121471242505933,0.0465993376875141,0.250419767546673
APOA2,Apolipoprotein A-II,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34603,-0.0227721792500089,0.0167499145235999,-0.0556020117162648,0.0100576532162469,0.174032199000526
APOA2,Apolipoprotein A-II,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34603,0.062075773439424,0.0550013257007249,-0.0457268249339968,0.169878371812845,0.259106864433426
APOA2,Apolipoprotein A-II,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34603,-0.0376578500813087,0.0688825522875306,-0.172667652564869,0.0973519524022512,0.584609811730582
APOA2,Apolipoprotein A-II,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34603,-0.0957973508992799,0.0778118579595858,-0.248308592500068,0.0567138907015082,0.218323746153407
APOA2,Apolipoprotein A-II,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34603,-0.0150467420467216,0.0639489476881883,-0.140386679515571,0.110293195422127,0.813990207138974
APOA2,Apolipoprotein A-II,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34603,0.0215686305260138,0.0277329892495601,-0.032788028403124,0.0759252894551516,0.436765346871121
APOA2,Apolipoprotein A-II,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34603,-0.043368535947312,0.0474011209796905,-0.136274733067505,0.0495376611728813,0.360271064919294
APOA2,Apolipoprotein A-II,Mental health,X29002.Recent lack of interest or pleasure in doing things,34576,0.0258641346920954,0.0723594869287006,-0.115960459688158,0.167688729072349,0.720776873746979
APOA2,Apolipoprotein A-II,Mental health,X29003.Recent feelings of depression,34565,0.053881662377718,0.070464924954185,-0.0842295905324846,0.19199291528792,0.444508035492453
APOA2,Apolipoprotein A-II,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34578,0.0531784848637286,0.0546830477844517,-0.0540002887937967,0.160357258521254,0.33085265339502
APOA2,Apolipoprotein A-II,Mental health,X29005.Recent feelings of tiredness or low energy,34581,0.0431232785769372,0.054517763921427,-0.0637315387090597,0.149978095862934,0.42898174569378
APOA2,Apolipoprotein A-II,Mental health,X29006.Recent poor appetite or overeating,34590,0.100133525731512,0.0830311314473664,-0.0626074919053259,0.262874543368351,0.227879760259689
APOA2,Apolipoprotein A-II,Mental health,X29007.Recent feelings of inadequacy,34561,0.0950658394340646,0.0786570086197182,-0.059101897460583,0.249233576328712,0.226865038747321
APOA2,Apolipoprotein A-II,Mental health,X29008.Recent trouble concentrating on things,34589,0.00674266234853849,0.0768591731365882,-0.143901316999174,0.157386641696251,0.930096527051713
APOA2,Apolipoprotein A-II,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34582,0.184593879700887,0.130969673577524,-0.0721066805110599,0.441294439912835,0.158762876734867
APOA2,Apolipoprotein A-II,Mental health,X29010.Recent thoughts of suicide or self-harm,34562,0.261139986974115,0.142744356600748,-0.0186389519633507,0.540918925911581,0.0673915377606434
APOA2,Apolipoprotein A-II,Mental health,X29038#0.Substances taken for depression_None of options listed,35428,-0.0413446292902971,0.030459901416782,-0.10104603606719,0.0183567774865956,0.174720392566149
APOA2,Apolipoprotein A-II,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35428,-0.0275618545834621,0.0755641993260783,-0.175667685262576,0.120543976095651,0.715312252513739
APOA2,Apolipoprotein A-II,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35428,-0.0273516073349246,0.0309268002055072,-0.0879681357377187,0.0332649210678695,0.376515385936377
APOA2,Apolipoprotein A-II,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35428,-0.032381310839774,0.101082085956628,-0.230502199314766,0.165739577635218,0.748716275656078
APOA2,Apolipoprotein A-II,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35428,-0.0491896450201077,0.0791064280950402,-0.204238244086386,0.105858954046171,0.534085583867942
APOA2,Apolipoprotein A-II,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35428,-0.0576673427703277,0.0855407071393673,-0.225327128763488,0.109992443222832,0.5002403926153
APOA2,Apolipoprotein A-II,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35428,-0.14530504610985,0.0867872393970253,-0.315408035328019,0.0247979431083201,0.0941282198253438
APOA2,Apolipoprotein A-II,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35428,-0.0684329621138704,0.0811080262362927,-0.227404693537004,0.0905387693092634,0.398854828947213
APOA2,Apolipoprotein A-II,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35428,0.0309420750566974,0.0545576853087444,-0.0759909881484416,0.137875138261836,0.570636632391863
APOA2,Apolipoprotein A-II,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35428,-0.0013243991784553,0.0279805615167516,-0.0561662997512884,0.0535175013943778,0.962249478545537
APOA2,Apolipoprotein A-II,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35428,-0.0122044144181184,0.0486262313638881,-0.107511827891339,0.0831029990551023,0.801834618324821
APOA2,Apolipoprotein A-II,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35428,0.0708486415974328,0.0763490229605179,-0.0787954434051822,0.220492726600048,0.353465588565092
APOA2,Apolipoprotein A-II,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35428,-0.0783208264091719,0.105295353557185,-0.284699719381255,0.128058066562911,0.457013202203211
APOA2,Apolipoprotein A-II,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35428,0.016103519845291,0.0754759432858201,-0.131829328994916,0.164036368685498,0.831053437744349
APOA2,Apolipoprotein A-II,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35428,0.030065978974195,0.107681797337926,-0.18099034380814,0.24112230175653,0.780091903314905
APOA2,Apolipoprotein A-II,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35428,-0.0254073420321041,0.101128901220644,-0.223619988424566,0.172805304360358,0.801639005497638
APOA2,Apolipoprotein A-II,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35428,-0.0746490233260355,0.0590656526908138,-0.19041770260003,0.0411196559479595,0.206337823922355
APOA2,Apolipoprotein A-II,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35428,-0.00743272345069975,0.0571502592989492,-0.11944723167664,0.104581784775241,0.896526465132454
APOA2,Apolipoprotein A-II,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35428,-0.0293424848556402,0.0831262035452815,-0.192269843804392,0.133584874093112,0.724109979924845
APOA2,Apolipoprotein A-II,Mental health,X29058.Recent feelings or nervousness or anxiety,34500,0.115126460547946,0.0652257626966301,-0.0127160343374491,0.242968955433341,0.0776136006040981
APOA2,Apolipoprotein A-II,Mental health,X29059.Recent inability to stop or control worrying,34513,0.124854357885841,0.0659943535026007,-0.00449457497925616,0.254203290750939,0.0585593191013163
APOA2,Apolipoprotein A-II,Mental health,X29060.Recent worrying too much about different things,34511,0.100188245692404,0.0616702259056987,-0.0206853970827653,0.221061888467574,0.104311271891188
APOA2,Apolipoprotein A-II,Mental health,X29061.Recent trouble relaxing,34508,0.0673847032567106,0.0665222120689392,-0.0629988323984103,0.197768238911832,0.311122794724177
APOA2,Apolipoprotein A-II,Mental health,X29062.Recent restlessness,34522,0.10969637917483,0.0964543597190121,-0.0793541658744343,0.298746924224093,0.255469100639175
APOA2,Apolipoprotein A-II,Mental health,X29063.Recent easy annoyance or irritability,34494,0.0521208404996678,0.0680706516550687,-0.0812976367442669,0.185539317743602,0.443896433471465
APOA2,Apolipoprotein A-II,Mental health,X29064.Recent feelings of foreboding,34497,0.265512969584234,0.0766720650847557,0.115235722018113,0.415790217150356,0.000538473774116894
APOA2,Apolipoprotein A-II,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35428,-0.0242720678325621,0.0349351093586597,-0.0927448821755352,0.0442007465104109,0.487221722230335
APOA2,Apolipoprotein A-II,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35428,-0.0497501623396623,0.0615666236505387,-0.170420744694718,0.0709204200153935,0.41908092579323
APOA2,Apolipoprotein A-II,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35428,-0.0878962622277812,0.0763849043038552,-0.237610674663337,0.061818150207775,0.249898988459689
APOA2,Apolipoprotein A-II,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35428,0.0307653586703662,0.0723536885806429,-0.111047870947694,0.172578588288426,0.670699815341483
APOA2,Apolipoprotein A-II,Mental health,X29065#2.Symptoms of panic attack_Sweating,35428,-0.0306860103105475,0.0528032080870965,-0.134180298161257,0.0728082775401617,0.561167698685501
APOA2,Apolipoprotein A-II,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35428,-0.0190801332866138,0.0579793217339653,-0.132719603885186,0.0945593373119583,0.742102389659321
APOA2,Apolipoprotein A-II,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35428,-0.0160769141857669,0.0587139167333786,-0.131156190983189,0.0990023626116552,0.784233732722226
APOA2,Apolipoprotein A-II,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35428,0.0167977620927462,0.0568676676252327,-0.0946628664527099,0.128258390638202,0.767710889231873
APOA2,Apolipoprotein A-II,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35428,0.0971929584760304,0.0717236142210281,-0.0433853253971847,0.237771242349246,0.17543351478944
APOA2,Apolipoprotein A-II,Mental health,X29076.Felt loved as a child,34494,0.0378795952789317,0.0571318666328149,-0.0740988633213855,0.149858053879249,0.507346314076707
APOA2,Apolipoprotein A-II,Mental health,X29077.Physically abused by family as a child,34515,0.0294032716989908,0.0836193022149806,-0.134490560642371,0.193297104040353,0.725127753149047
APOA2,Apolipoprotein A-II,Mental health,X29078.Felt hated by family member as a child,34501,-0.098666534999219,0.0836875101233917,-0.262694054841067,0.0653609848426288,0.238456005917493
APOA2,Apolipoprotein A-II,Mental health,X29079.Sexually molested as a child,34460,0.00719136256614229,0.106821300419489,-0.202178386256056,0.21656111138834,0.946328375130699
APOA2,Apolipoprotein A-II,Mental health,X29080.Someone to take to doctor when needed as a child,34479,-0.0190808269791121,0.0784160715301411,-0.172776327178189,0.134614673219964,0.807760753154504
APOA2,Apolipoprotein A-II,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34503,0.259942583947911,0.121614659889038,0.0215778505653971,0.498307317330425,0.0326087543961011
APOA2,Apolipoprotein A-II,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34469,-0.0057338850470307,0.092621532733746,-0.187272089205173,0.175804319111111,0.950639549897929
APOA2,Apolipoprotein A-II,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34508,-0.0408588110890029,0.106530573488175,-0.249658735125826,0.16794111294782,0.70133424254042
APOA2,Apolipoprotein A-II,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34496,-0.0846687647734762,0.148472458709509,-0.375674783844113,0.206337254297161,0.56852160492932
APOA2,Apolipoprotein A-II,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34497,-0.0491883258378068,0.136012411686531,-0.315772652743408,0.217396001067794,0.717631099303761
APOA2,Apolipoprotein A-II,Mental health,X29086.Experienced a violent or sexual assault,34511,0.10921631033196,0.129703025534354,-0.145001619715374,0.363434240379295,0.399798373846977
APOA2,Apolipoprotein A-II,Mental health,X29087.Experienced a life-threatening injury or illness,34508,0.091761499141295,0.0625504163352497,-0.0308373168757944,0.214360315158384,0.142435076093866
APOA2,Apolipoprotein A-II,Mental health,X29088.Experienced a marital separation or divorce,34510,0.0370405461985057,0.063423383270416,-0.0872692850115097,0.161350377408521,0.559231408516291
APOA2,Apolipoprotein A-II,Mental health,X29089.Experienced the death of a spouse or partner,34518,-0.0188675855354769,0.0689705025709009,-0.154049770574443,0.116314599503489,0.784433225043324
APOA2,Apolipoprotein A-II,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34507,0.0525279585939293,0.0813941502146262,-0.107004575826738,0.212060493014597,0.518726329896789
APOA2,Apolipoprotein A-II,Lifestyle factors,X29091.Frequency of drinking alcohol,34505,0.0154849219085818,0.0513422554151633,-0.0851458987051383,0.116115742522302,0.762967372458645
APOA2,Apolipoprotein A-II,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33854,0.0083919515693,0.0633887283062078,-0.115849955910867,0.132633859049467,0.894682568609508
APOA2,Apolipoprotein A-II,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33875,0.0171192298490885,0.0659996780303249,-0.112240139090348,0.146478598788525,0.795350745153751
APOA2,Apolipoprotein A-II,Mental health,X29104.Ever used cannabis,34507,0.0695771831613402,0.0935712003762307,-0.113822369576072,0.252976735898752,0.457166674261253
APOA2,Apolipoprotein A-II,Mental health,X29108.Ever thought that life not worth living,34482,0.0360763851765141,0.0694847552670923,-0.100113735146987,0.172266505500015,0.603644012692627
APOA2,Apolipoprotein A-II,Mental health,X29109.Ever contemplated self-harm,34500,0.0147871558215872,0.104066073290131,-0.18918234782707,0.218756659470244,0.887011219973768
APOA2,Apolipoprotein A-II,Mental health,X29111.Ever self-harmed,34507,0.0461842422005232,0.184249733952746,-0.314945236346859,0.407313720747906,0.80208582759644
APOA2,Apolipoprotein A-II,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34494,-0.0871574788347345,0.103985853746311,-0.290969752177505,0.116654794508036,0.401974896351726
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35988,-0.149300626624903,0.0833133947982898,-0.312594880429551,0.0139936271797452,0.0731716359143827
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35988,-0.0715535641753294,0.0620979610073674,-0.193265567749769,0.0501584393991106,0.249251036221608
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35988,-0.103244467887258,0.0725868517787207,-0.245514697373551,0.0390257615990341,0.154968343144017
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35988,-0.106323199628994,0.110562096152809,-0.323024908088499,0.110378508830512,0.336254398743312
APOA2,Apolipoprotein A-II,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34487,0.0655270853220434,0.0595828508921205,-0.0512553024265127,0.1823094730706,0.271484907463888
APOA2,Apolipoprotein A-II,Health and medical history,X29153.Pain or discomfort today,34498,0.0582572344101455,0.053936986681673,-0.0474592594859335,0.163973728306225,0.280147656016369
APOA2,Apolipoprotein A-II,Mental health,X29154.Anxiety or depression today,34498,0.100954069963297,0.0698542276123683,-0.0359602161569451,0.237868356083539,0.148457850768016
APOA2,Apolipoprotein A-II,Mental health,X29166.Frequency of confiding in someone close,34337,-0.0372388654631896,0.0533556510585834,-0.141815941538013,0.0673382106116338,0.485248376878291
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34483,0.0197202477109302,0.0145206934158216,-0.00874031138408004,0.0481808068059405,0.174496570659354
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34483,0.00283970384862974,0.0148571384322112,-0.0262802874785042,0.0319596951757637,0.848427970563709
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34483,-0.0051469894685054,0.0184879530143869,-0.0413833773767037,0.0310893984396929,0.780718554467817
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34483,-0.0209232882143654,0.017114871419581,-0.0544684361967441,0.0126218597680134,0.221565175498895
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34483,-0.0675265950928682,0.0290899531651052,-0.124542903296474,-0.0105102868892621,0.0203083131170239
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34483,-0.0132661797434687,0.0140696791688302,-0.040842750914376,0.0143103914274385,0.345779511220448
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34482,0.00530796548189988,0.0150446651662753,-0.0241795782439998,0.0347955092077995,0.724242099495582
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34482,0.0227802529082526,0.0231206418942879,-0.0225362052045517,0.0680967110210569,0.324532760337444
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34482,-0.00740173373930372,0.0337136622132583,-0.07348051167729,0.0586770441986826,0.82623243809125
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34482,-0.00991705195991903,0.0268819660819113,-0.0626057054804653,0.0427716015606272,0.7122088618416
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34482,-0.106826306324038,0.0443436045575056,-0.193739771256749,-0.0199128413913272,0.0160277356421986
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34482,-0.00104232783925733,0.0203101583164162,-0.0408502381394331,0.0387655824609184,0.959072057274105
APOA2,Apolipoprotein A-II,Mental health,X29171.Frequency of feeling 'in tune' with people,34395,0.0336244115631251,0.0680167980160114,-0.0996885125482573,0.166937335674507,0.62107671007258
APOA2,Apolipoprotein A-II,Mental health,X29172.Freuency of feeling that lacks companionship,34464,-0.00625829880931494,0.0614141067591554,-0.12662994805726,0.11411335043863,0.918837325431906
APOA2,Apolipoprotein A-II,Mental health,X29173.Frequency of feeling left out,34429,-0.119550283889147,0.0655973732567944,-0.248121135472464,0.0090205676941698,0.068438330749137
APOA2,Apolipoprotein A-II,Mental health,X29174.Frequency of feeling isolated from others,34456,-0.0903425528078888,0.0677581591947845,-0.223148544829666,0.0424634392138889,0.182488200621715
APOA2,Apolipoprotein A-II,Mental health,X29175.Tendency to bounce back quickly after hard times,34494,0.0106858093973632,0.054320544799795,-0.095782458410235,0.117154077204961,0.844056051704546
APOA2,Apolipoprotein A-II,Mental health,X29176.Ability to make it through stressful events,34494,0.010602517141431,0.0518816310732271,-0.0910854797620941,0.112290514044956,0.838080232654639
APOA2,Apolipoprotein A-II,Mental health,X29177.Quick recovery from stressful events,34494,-0.0175876290962007,0.0534880923647054,-0.122424290131023,0.0872490319386219,0.742309342824043
APOA2,Apolipoprotein A-II,Mental health,X29178.Hard to snap back when something bad happens,34494,-0.0567413927685955,0.0521360739040419,-0.158928097620518,0.0454453120833265,0.27649778525888
APOA2,Apolipoprotein A-II,Mental health,X29179.Comes through difficult times with little trouble,34494,0.0053845556181473,0.0530682276511688,-0.0986291705781435,0.109398281814438,0.919185361409052
APOA2,Apolipoprotein A-II,Mental health,X29180.Tendency to take a long time to get over setbacks,34494,-0.0162915353929691,0.0524394550713891,-0.119072867332892,0.0864897965469535,0.756061266518143
APOA2,Apolipoprotein A-II,Mental health,X29181.General happiness,34469,0.0181962051494366,0.0547924856012341,-0.0891970666289822,0.125589476927856,0.739832181901588
APOA2,Apolipoprotein A-II,Mental health,X29182.Belief that own life is meaningful,34384,-0.00911049243902633,0.0551886772834823,-0.117280299914652,0.099059315036599,0.868888223513989
APOA2,Apolipoprotein A-II,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34773,0.0257229007530184,0.0467740128662454,-0.0659541644648226,0.117399965970859,0.58238254032699
APOA2,Apolipoprotein A-II,Health and medical history,X2946.Father's age,30050,0.037563259210633,0.032639103204446,-0.0264093830700812,0.101535901491347,0.250108427518892
APOA2,Apolipoprotein A-II,Health and medical history,X2966.Age high blood pressure diagnosed,35738,-0.0213782773619877,0.00723705758674519,-0.0355629102320082,-0.00719364449196709,0.00314799403259705
APOA2,Apolipoprotein A-II,Blood and urine assays,X30000.White blood cell (leukocyte) count,48706,-0.0232494312618042,0.00393264952348589,-0.0309574243278365,-0.0155414381957718,3.43815687608661e-09
APOA2,Apolipoprotein A-II,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48707,-0.0462453713260099,0.00418358643617265,-0.0544452007409083,-0.0380455419111115,2.54442560931073e-28
APOA2,Apolipoprotein A-II,Blood and urine assays,X30020.Haemoglobin concentration,48707,-0.0681544096176378,0.00450408364798024,-0.0769824135676791,-0.0593264056675966,1.96044577569998e-51
APOA2,Apolipoprotein A-II,Blood and urine assays,X30030.Haematocrit percentage,48707,-0.0504841987423959,0.00438735215886594,-0.0590834089737732,-0.0418849885110187,1.5305725572717e-30
APOA2,Apolipoprotein A-II,Blood and urine assays,X30040.Mean corpuscular volume,48707,0.00569289495654344,0.00381374429538485,-0.00178204386241087,0.0131678337754978,0.135523740135941
APOA2,Apolipoprotein A-II,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48707,-0.0127359038991289,0.00382334851915661,-0.0202296669966758,-0.00524214080158192,0.000866682994184299
APOA2,Apolipoprotein A-II,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48707,-0.0355967244418398,0.00373088157960836,-0.0429092523378722,-0.0282841965458074,1.57463843377883e-21
APOA2,Apolipoprotein A-II,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48707,0.0447516113660723,0.00384303705208693,0.037219258743982,0.0522839639881627,3.09213158622305e-31
APOA2,Apolipoprotein A-II,Blood and urine assays,X30080.Platelet count,48707,0.0100805091043731,0.00378229177415235,0.00266721722703447,0.0174938009817117,0.00770091963483628
APOA2,Apolipoprotein A-II,Blood and urine assays,X30090.Platelet crit,48707,0.0115238302728759,0.00385964038875485,0.00395893511091636,0.0190887254348354,0.00283256571365481
APOA2,Apolipoprotein A-II,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48707,-0.00125756869400211,0.00360185782179362,-0.00831721002471759,0.00580207263671338,0.72698462949053
APOA2,Apolipoprotein A-II,Blood and urine assays,X30110.Platelet distribution width,48707,-0.0094241446639268,0.00375168671157547,-0.0167774506186147,-0.00207083870923889,0.0120137509694898
APOA2,Apolipoprotein A-II,Blood and urine assays,X30120.Lymphocyte count,48673,-0.0547341009286061,0.00367678351447387,-0.0619405966169749,-0.0475276052402374,7.59247764783426e-50
APOA2,Apolipoprotein A-II,Blood and urine assays,X30130.Monocyte count,48673,-0.0243369461026553,0.00378971542889909,-0.0317647883432976,-0.0169091038620131,1.37747924138889e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30140.Neutrophill count,48673,-0.000637248689266273,0.00390553659510548,-0.00829210041567301,0.00701760303714046,0.870389850441512
APOA2,Apolipoprotein A-II,Blood and urine assays,X30150.Eosinophill count,48673,-0.00445957528835924,0.00373023616348001,-0.0117708381687801,0.00285168759206157,0.2318981300985
APOA2,Apolipoprotein A-II,Blood and urine assays,X30160.Basophill count,48673,-0.0566899533592567,0.0287786169718984,-0.113096042624178,-0.000283864094335784,0.0488681375281971
APOA2,Apolipoprotein A-II,Blood and urine assays,X30170.Nucleated red blood cell count,48673,0.0848574304056005,0.145270846485342,-0.199873428705669,0.36958828951687,0.559137899732804
APOA2,Apolipoprotein A-II,Blood and urine assays,X30180.Lymphocyte percentage,48674,-0.0415249409723667,0.00367819774227642,-0.0487342085472285,-0.0343156733975049,1.82620443956118e-29
APOA2,Apolipoprotein A-II,Blood and urine assays,X30190.Monocyte percentage,48674,-0.00951458693648057,0.00375522572164294,-0.0168748293509007,-0.0021543445220604,0.0112945466122408
APOA2,Apolipoprotein A-II,Blood and urine assays,X30200.Neutrophill percentage,48674,0.0367214125903063,0.00366143487632638,0.0295450002327066,0.043897824947906,1.29379567539467e-23
APOA2,Apolipoprotein A-II,Blood and urine assays,X30210.Eosinophill percentage,48674,0.00242886813083681,0.00370846388643462,-0.00483972108657504,0.00969745734824865,0.512505994443125
APOA2,Apolipoprotein A-II,Blood and urine assays,X30220.Basophill percentage,48674,0.000385341286583718,0.00369784700147251,-0.0068624388363024,0.00763312140946983,0.917006206735584
APOA2,Apolipoprotein A-II,Blood and urine assays,X30230.Nucleated red blood cell percentage,48673,0.0853198090284472,0.14513633979793,-0.199147416975496,0.36978703503239,0.556633265685692
APOA2,Apolipoprotein A-II,Blood and urine assays,X30240.Reticulocyte percentage,48351,-0.0103235575235324,0.00399752579242117,-0.0181587080766779,-0.00248840697038691,0.00981646050888569
APOA2,Apolipoprotein A-II,Blood and urine assays,X30250.Reticulocyte count,48351,-0.0204021522771859,0.00407193807142543,-0.0283831508971797,-0.012421153657192,5.4792575299669e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30260.Mean reticulocyte volume,48351,0.034926140209313,0.00373613747115151,0.027603310765856,0.04224896965277,9.86931481644324e-21
APOA2,Apolipoprotein A-II,Blood and urine assays,X30270.Mean sphered cell volume,48351,0.0124935943281741,0.00379799972580963,0.00504951486558722,0.019937673790761,0.00100539651046482
APOA2,Apolipoprotein A-II,Blood and urine assays,X30280.Immature reticulocyte fraction,48351,0.0102073474820836,0.00395447876187254,0.00245656910881343,0.0179581258553538,0.00985277691126704
APOA2,Apolipoprotein A-II,Blood and urine assays,X30290.High light scatter reticulocyte percentage,48351,-0.00335836942665372,0.00407641831479194,-0.0113481493236459,0.00463141047033849,0.410033349359542
APOA2,Apolipoprotein A-II,Blood and urine assays,X30300.High light scatter reticulocyte count,48351,-0.0117818160154604,0.00413111981792031,-0.0198788108585842,-0.00368482117233661,0.00434961344571482
APOA2,Apolipoprotein A-II,Blood and urine assays,X30500.Microalbumin in urine,36087,0.0486694784812082,0.00645693530200969,0.0360138852892692,0.0613250716731472,5.40208198718617e-14
APOA2,Apolipoprotein A-II,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48687,-0.0146016510976359,0.00412318843119976,-0.0226831004227874,-0.00652020177248439,0.000399014655962242
APOA2,Apolipoprotein A-II,Blood and urine assays,X30520.Potassium in urine,48655,-0.0158095608078821,0.00385508312076976,-0.0233655237245908,-0.00825359789117336,4.13102452626166e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30530.Sodium in urine,48637,-0.0214332684086136,0.00405724780782682,-0.0293854741119542,-0.0134810627052731,1.28656724384391e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30600.Albumin,46745,0.01454966383901,0.00397070368805588,0.00676708461042049,0.0223322430675995,0.000248791686723456
APOA2,Apolipoprotein A-II,Blood and urine assays,X30610.Alkaline phosphatase,48324,-0.024522681104038,0.00394263767296824,-0.0322502509430558,-0.0167951112650203,5.07899069848279e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30620.Alanine aminotransferase,48328,-0.0307365974182092,0.00417525854689863,-0.0389201041701305,-0.0225530906662879,1.89074000211664e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30630.Apolipoprotein A,46617,0.155766819311431,0.00419099982039971,0.147552459663447,0.163981178959414,4.809711777009e-291
APOA2,Apolipoprotein A-II,Blood and urine assays,X30640.Apolipoprotein B,48241,-0.0402616551440365,0.00363271703486356,-0.047381780532369,-0.0331415297557039,1.85219547884211e-28
APOA2,Apolipoprotein A-II,Blood and urine assays,X30650.Aspartate aminotransferase,48269,0.0162277680188462,0.00399253642822746,0.00840239661952039,0.024053139418172,4.83230379115982e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30660.Direct bilirubin,45531,0.045740985244742,0.00416938547218168,0.0375689897192659,0.0539129807702181,6.61655823392036e-28
APOA2,Apolipoprotein A-II,Blood and urine assays,X30670.Urea,48316,0.0295475082995576,0.00392271714905753,0.0218589826874048,0.0372360339117103,5.20260883795568e-14
APOA2,Apolipoprotein A-II,Blood and urine assays,X30680.Calcium,46743,0.0247656634586745,0.00386306033898247,0.0171940651942689,0.0323372617230802,1.48360078246284e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30690.Cholesterol,48331,-0.00935731838578469,0.00368548385800003,-0.0165808667474647,-0.00213377002410464,0.0111259110544033
APOA2,Apolipoprotein A-II,Blood and urine assays,X30700.Creatinine,48324,0.0988299351066081,0.00437746394680293,0.0902501057708743,0.107409764442342,2.07828691461248e-111
APOA2,Apolipoprotein A-II,Blood and urine assays,X30710.C-reactive protein,48273,-0.036153438537574,0.0041561258177799,-0.0442994451404226,-0.0280074319347254,3.62085308989156e-18
APOA2,Apolipoprotein A-II,Blood and urine assays,X30720.Cystatin C,48339,0.130016303612355,0.00423228917015242,0.121721016838856,0.138311590385853,2.44435385789895e-202
APOA2,Apolipoprotein A-II,Blood and urine assays,X30730.Gamma glutamyltransferase,48324,0.019845295528882,0.00422329536894149,0.0115676366057567,0.0281229544520073,2.63248223199491e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30740.Glucose,46729,-0.0110742786858864,0.00396601673970395,-0.0188476714957061,-0.00330088587606665,0.00523926904773888
APOA2,Apolipoprotein A-II,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48329,-0.0045960139266749,0.00404901072925126,-0.0125320749560074,0.00334004710265756,0.256349517669508
APOA2,Apolipoprotein A-II,Blood and urine assays,X30760.HDL cholesterol,46736,0.155141609793913,0.00432887681819422,0.146657011230252,0.163626208357574,1.5599557341257e-271
APOA2,Apolipoprotein A-II,Blood and urine assays,X30770.IGF-1,48221,-0.0207068373766201,0.00386773573644178,-0.028287599420046,-0.0131260753331943,8.71551521892325e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30780.LDL direct,48286,-0.0364263546577345,0.00360537938501893,-0.0434928982523716,-0.0293598110630974,6.1333638460735e-24
APOA2,Apolipoprotein A-II,Blood and urine assays,X30790.Lipoprotein A,44436,-0.00997640369639786,0.0041094718494496,-0.0180309685213191,-0.00192183887147663,0.0152080505157318
APOA2,Apolipoprotein A-II,Blood and urine assays,X30810.Phosphate,46712,0.0306861716172604,0.00413512737804544,0.0225813219562914,0.0387910212782295,1.21693713994239e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30830.SHBG,46585,0.11069770558619,0.00470733879821653,0.101471321541685,0.119924089630694,2.10622474410346e-120
APOA2,Apolipoprotein A-II,Blood and urine assays,X30840.Total bilirubin,48251,0.0416951744486347,0.00405300198954318,0.03375129054913,0.0496390583481393,9.31574156360432e-25
APOA2,Apolipoprotein A-II,Blood and urine assays,X30850.Testosterone,46073,0.0285434155881982,0.00636742294820286,0.0160632666097206,0.0410235645666758,7.41804222689386e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30860.Total protein,46730,0.00961014937846362,0.0038661876911069,0.00203242150389408,0.0171878772530331,0.012939247804737
APOA2,Apolipoprotein A-II,Blood and urine assays,X30870.Triglycerides,48320,-0.0881620088583537,0.00415660544422269,-0.0963089555290301,-0.0800150621876772,1.0543768744593e-98
APOA2,Apolipoprotein A-II,Blood and urine assays,X30880.Urate,48300,0.0234231740656861,0.00458165877363991,0.0144431228693519,0.0324032252620204,3.21197469059587e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30890.Vitamin D,47361,0.0194453464604944,0.00426549085431412,0.0110849843860387,0.02780570853495,5.17922816783844e-06
APOA2,Apolipoprotein A-II,Physical measures,X3137.Number of measurements made,47082,-0.0104819113191237,0.0341115152509416,-0.0773404812109692,0.0563766585727218,0.75863104777467
APOA2,Apolipoprotein A-II,Physical measures,X3143.Ankle spacing width,40505,0.00869341476246432,0.00647307718130973,-0.00399381651290275,0.0213806460378314,0.179295313973714
APOA2,Apolipoprotein A-II,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40505,-0.0319915672055011,0.00505065039221293,-0.0418908419742384,-0.0220922924367638,2.47713151263e-10
APOA2,Apolipoprotein A-II,Physical measures,X3146.Speed of sound through heel,40505,-0.0242005915399635,0.00485057745274847,-0.0337077233473505,-0.0146934597325765,6.15252975006687e-07
APOA2,Apolipoprotein A-II,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40505,-0.0278346194597077,0.00490922949741388,-0.0374567092746389,-0.0182125296447765,1.46419203218012e-08
APOA2,Apolipoprotein A-II,Physical measures,X3148.Heel bone mineral density (BMD),40494,-0.0267389063446891,0.00491790104797004,-0.0363779923987104,-0.0170998202906678,5.52947647755215e-08
APOA2,Apolipoprotein A-II,Health and medical history,X3526.Mother's age at death,45851,-0.00247599965131528,0.00384292695744278,-0.0100081364879031,0.00505613718527258,0.519389481773868
APOA2,Apolipoprotein A-II,Health and medical history,X3581.Age at menopause (last menstrual period),37334,-0.00768010576721323,0.00530961968668571,-0.0180869603531172,0.00272674881869076,0.148089188656909
APOA2,Apolipoprotein A-II,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32353,-0.00334739510042214,0.00825313272000491,-0.0195235352316318,0.0128287450307875,0.685070721785958
APOA2,Apolipoprotein A-II,Physical measures,X4100.Ankle spacing width (left),35857,0.00860956035714706,0.00855819857052996,-0.00816450884109166,0.0253836295553858,0.314451393608227
APOA2,Apolipoprotein A-II,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35855,-0.0270308685240169,0.00668128108927228,-0.0401261794589906,-0.0139355575890432,5.27429286015875e-05
APOA2,Apolipoprotein A-II,Physical measures,X4103.Speed of sound through heel (left),35857,-0.020842300115748,0.00638910777085962,-0.0333649513466328,-0.00831964888486311,0.00111122835040641
APOA2,Apolipoprotein A-II,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35857,-0.0234092865640904,0.00647676199078289,-0.0361037400660248,-0.0107148330621559,0.000303323380293428
APOA2,Apolipoprotein A-II,Physical measures,X4105.Heel bone mineral density (BMD) (left),35854,-0.0235746100190351,0.0064702797283716,-0.0362563582866434,-0.0108928617514268,0.000270978126782112
APOA2,Apolipoprotein A-II,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35857,-0.0234067632701562,0.00647676627255575,-0.0361012251643655,-0.0107123013759469,0.00030378166861811
APOA2,Apolipoprotein A-II,Physical measures,X4119.Ankle spacing width (right),35856,0.00688626113223237,0.00847452964589097,-0.00972381697371393,0.0234963392381787,0.416486054327947
APOA2,Apolipoprotein A-II,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35855,-0.0310620894879086,0.00663520772657188,-0.0440670966319895,-0.0180570823438277,2.9055648000084e-06
APOA2,Apolipoprotein A-II,Physical measures,X4122.Speed of sound through heel (right),35856,-0.024471887365016,0.00634050385792375,-0.0368992749265465,-0.0120444998034854,0.00011464045733545
APOA2,Apolipoprotein A-II,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35856,-0.0274985766341681,0.00642757295332361,-0.0400966196226824,-0.0149005336456538,1.91028948890956e-05
APOA2,Apolipoprotein A-II,Physical measures,X4124.Heel bone mineral density (BMD) (right),35852,-0.0273387225411446,0.00641925260509115,-0.0399204576471233,-0.014756987435166,2.0829561196918e-05
APOA2,Apolipoprotein A-II,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35856,-0.027500995713952,0.00642755714481926,-0.0400990077177978,-0.0149029837101063,1.90698187197666e-05
APOA2,Apolipoprotein A-II,Physical measures,X4194.Pulse rate,36169,-0.0284930945200035,0.00611821651204218,-0.0404847988836062,-0.0165013901564008,3.26647572033952e-06
APOA2,Apolipoprotein A-II,Physical measures,X4195.Pulse wave reflection index,36169,-0.0116690225218225,0.00658647090925138,-0.0245785055039552,0.00124046046031016,0.0764937717904329
APOA2,Apolipoprotein A-II,Physical measures,X4196.Pulse wave peak to peak time,36164,0.0146612223596741,0.00605115721088769,0.00280095422633428,0.026521490493014,0.0154233637440001
APOA2,Apolipoprotein A-II,Physical measures,X4198.Position of the pulse wave peak,36169,-0.0169984492973481,0.00641698951744268,-0.0295757487515357,-0.00442114984316044,0.00809180661303705
APOA2,Apolipoprotein A-II,Physical measures,X4199.Position of pulse wave notch,36169,-0.015273438532553,0.00614770086649323,-0.0273229322308797,-0.00322394483422625,0.0129997428468633
APOA2,Apolipoprotein A-II,Physical measures,X4200.Position of the shoulder on the pulse waveform,36169,-0.0156837519272022,0.00631416450641121,-0.0280595143597682,-0.00330798949463621,0.0130185379800126
APOA2,Apolipoprotein A-II,Physical measures,X4269.Number of triplets attempted (left),36006,-0.0959361223310141,0.129351066881166,-0.349464213418099,0.157591968756071,0.45831143881964
APOA2,Apolipoprotein A-II,Physical measures,X4270.Volume level set by participant (left),35926,0.0321400361491224,0.0440050756892687,-0.0541099122018443,0.118389984500089,0.465188797001995
APOA2,Apolipoprotein A-II,Physical measures,X4276.Number of triplets attempted (right),36003,-0.0938513827022167,0.126930658932079,-0.342635474209091,0.154932708804658,0.459695163100057
APOA2,Apolipoprotein A-II,Physical measures,X4277.Volume level set by participant (right),35920,-0.00708156622642969,0.0441415137260484,-0.0935989331294846,0.0794358006766252,0.872548192925631
APOA2,Apolipoprotein A-II,Cognitive function,X4288.Time to answer,36174,-0.00390240527449657,0.00728963847422607,-0.0181900966839797,0.0103852861349865,0.592434651299459
APOA2,Apolipoprotein A-II,Cognitive function,X4290.Duration screen displayed,36174,0.00520140465882305,0.00678674727062418,-0.00810061999160035,0.0185034293092465,0.443460609211008
APOA2,Apolipoprotein A-II,Physical measures,X46.Hand grip strength (left),49224,-0.041548661025126,0.00530456186244301,-0.0519456022755143,-0.0311517197747377,5.01468448584993e-15
APOA2,Apolipoprotein A-II,Physical measures,X47.Hand grip strength (right),49243,-0.0349791411959126,0.00527257646482605,-0.0453133910669716,-0.0246448913248535,3.34675038601185e-11
APOA2,Apolipoprotein A-II,Physical measures,X48.Waist circumference,49305,-0.0492092159741118,0.00804322136208274,-0.064973929843794,-0.0334445021044297,9.64492458041623e-10
APOA2,Apolipoprotein A-II,Health and medical history,X4803.Tinnitus,36088,0.00960757143728831,0.0488337452583759,-0.0861065692691284,0.105321712143705,0.844036481385842
APOA2,Apolipoprotein A-II,Working and living environment,X4825.Noisy workplace,36161,0.0338838593350358,0.0568058782267643,-0.0774556619894223,0.145223380659494,0.550870597826704
APOA2,Apolipoprotein A-II,Working and living environment,X4836.Loud music exposure frequency,36116,-0.0901770961249943,0.09364770870866,-0.273726605193968,0.0933724129439793,0.335611434188644
APOA2,Apolipoprotein A-II,Physical measures,X49.Hip circumference,49300,-0.00833980338319249,0.00653425380723492,-0.0211469408453729,0.00446733407898795,0.201856918581019
APOA2,Apolipoprotein A-II,Physical measures,X50.Standing height,49286,-0.0184182140380952,0.00518614822829751,-0.0285830645655583,-0.00825336351063207,0.000384028305463438
APOA2,Apolipoprotein A-II,Health and medical history,X5057.Number of older siblings,35094,-0.00831409874843738,0.0477675331388589,-0.101938463700601,0.085310266203726,0.861829514171046
APOA2,Apolipoprotein A-II,Physical measures,X51.Seated height,49211,-0.0283661938775828,0.0048457668489024,-0.0378638969014315,-0.0188684908537341,4.87942012036269e-09
APOA2,Apolipoprotein A-II,Eye measures,X5181.Ever had eye surgery,33900,0.0763878509533311,0.0981507965353755,-0.115987710256005,0.268763412162667,0.436448817844211
APOA2,Apolipoprotein A-II,Eye measures,X5186.Duration visual-acuity screen displayed (right),33887,0.0132218791072035,0.00735525313389665,-0.00119441703523391,0.027638175249641,0.0723030362055307
APOA2,Apolipoprotein A-II,Eye measures,X5188.Duration visual-acuity screen displayed (left),33886,0.019528950212625,0.00761587339865962,0.00460183835125217,0.0344560620739979,0.0103709668866603
APOA2,Apolipoprotein A-II,Eye measures,X5190.Duration at which refractometer first shown (right),33824,0.0208204088554524,0.00780073900433359,0.00553096040695853,0.0361098573039462,0.00763359493804897
APOA2,Apolipoprotein A-II,Eye measures,X5193.Duration at which refractometer first shown (left),33822,0.0247824251590824,0.0078849164116944,0.00932798899216143,0.0402368613260035,0.00168273220474997
APOA2,Apolipoprotein A-II,Eye measures,"X5199.logMAR, initial (right)",33872,0.0371580676425969,0.056080717497209,-0.0727601386519327,0.147076273937127,0.507631022674492
APOA2,Apolipoprotein A-II,Eye measures,X5200.Final number of letters displayed (right),33872,-0.188544759909569,0.329570590629445,-0.83450311754328,0.457413597724143,0.567287023280905
APOA2,Apolipoprotein A-II,Eye measures,"X5201.logMAR, final (right)",33818,0.00948413724259113,0.00819141096184534,-0.00657102824262573,0.025539302727808,0.246999402050837
APOA2,Apolipoprotein A-II,Eye measures,X5202.Number of rounds to result (right),33872,0.0492627687211943,0.0515615914251158,-0.0517979504720326,0.150323487914421,0.339416857475937
APOA2,Apolipoprotein A-II,Eye measures,"X5206.logMAR, initial (left)",33867,0.0796104474059554,0.0561181149888558,-0.030381057972202,0.189601952784113,0.15607566551609
APOA2,Apolipoprotein A-II,Eye measures,X5207.Final number of letters displayed (left),33867,-0.311392290032954,0.293822727377911,-0.88728483569366,0.264500255627751,0.28929199936031
APOA2,Apolipoprotein A-II,Eye measures,"X5208.logMAR, final (left)",33817,0.015732814761971,0.00809472750199214,-0.000132851141933649,0.0315984806658756,0.0520057671459817
APOA2,Apolipoprotein A-II,Eye measures,X5209.Number of rounds to result (left),33865,0.00898724212513413,0.0517793108531978,-0.0925002071471335,0.110474691397402,0.862212358926731
APOA2,Apolipoprotein A-II,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33652,-0.0174408441322633,0.00754206133077941,-0.032223284340591,-0.0026584039239357,0.0207967334656616
APOA2,Apolipoprotein A-II,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33652,-0.0239701739041521,0.00760419016181978,-0.0388743866213189,-0.00906596118698535,0.00163102181817611
APOA2,Apolipoprotein A-II,Eye measures,X5256.Corneal hysteresis (right),33652,-0.000891628471017233,0.00760243493265505,-0.0157924009390211,0.0140091439969867,0.906641903357324
APOA2,Apolipoprotein A-II,Eye measures,X5257.Corneal resistance factor (right),33652,-0.0146783292478677,0.00765821878319815,-0.0296884380629361,0.000331779567200655,0.055342884602351
APOA2,Apolipoprotein A-II,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33643,-0.0235708489228734,0.00761202392658438,-0.0384904158189788,-0.00865128202676799,0.00197019929473045
APOA2,Apolipoprotein A-II,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33643,-0.0229064671440076,0.00763684447381216,-0.0378746823126795,-0.00793825197533579,0.00271949997827016
APOA2,Apolipoprotein A-II,Eye measures,X5264.Corneal hysteresis (left),33643,0.00718758284003135,0.00775411815620357,-0.00801048874612765,0.0223856544261903,0.354009269830763
APOA2,Apolipoprotein A-II,Eye measures,X5265.Corneal resistance factor (left),33643,-0.00543510347589937,0.00775746281317166,-0.0206397305897158,0.00976952363791708,0.483571208878912
APOA2,Apolipoprotein A-II,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33978,0.0690984476323251,0.298742855855577,-0.516437549844607,0.654634445109257,0.817093655362832
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",49258,0.0141624842548959,0.019653828658503,-0.0243590199157699,0.0526839884255617,0.47116607423852
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",49258,0.0715705244763327,0.0210416634884048,0.0303288640390592,0.112812184913606,0.0006717927622571
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",49258,0.0212411138097784,0.0562183055434083,-0.0889467650553018,0.131428992674859,0.70555888177386
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",49258,0.0194616479182322,0.00844467989132473,0.00291007533123573,0.0360132205052286,0.0211988893887322
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",49258,-0.0222555062897626,0.00795415370315123,-0.0378456475479391,-0.00666536503158622,0.00514734463685396
APOA2,Apolipoprotein A-II,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37074,-0.031631543348844,0.011690193805727,-0.0545443232080689,-0.00871876348961917,0.00682828945322301
APOA2,Apolipoprotein A-II,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37074,0.0351344111279431,0.0247502863133313,-0.0133761500461863,0.0836449723020725,0.155776613614678
APOA2,Apolipoprotein A-II,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37074,-0.0441780232256412,0.030547978131941,-0.104052060364246,0.0156960139129632,0.148165133114327
APOA2,Apolipoprotein A-II,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37074,0.0125402693945451,0.0166589413059751,-0.020111255565166,0.0451917943542563,0.451613577162091
APOA2,Apolipoprotein A-II,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,49319,0.00447332198985067,0.0163391398624897,-0.0275513921406291,0.0364980361203305,0.784256867155605
APOA2,Apolipoprotein A-II,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,49319,0.00447332198985067,0.0163391398624897,-0.0275513921406291,0.0364980361203305,0.784256867155605
APOA2,Apolipoprotein A-II,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),49319,0.0055139125709633,0.0131997649115665,-0.020357626655707,0.0313854517976336,0.676150389482842
APOA2,Apolipoprotein A-II,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',49319,-0.00537756163957261,0.0224422403102178,-0.0493643526475995,0.0386092293684543,0.810628956604895
APOA2,Apolipoprotein A-II,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),49319,0.0635098771166266,0.0556722376494303,-0.0456077086762569,0.17262746290951,0.25397429887982
APOA2,Apolipoprotein A-II,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),49319,0.0573324704610288,0.0368225195141777,-0.0148396677867596,0.129504608708817,0.11948745056329
APOA2,Apolipoprotein A-II,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,49319,-0.0169315913323027,0.0601261132279599,-0.134778773259104,0.100915590594499,0.778252142646428
APOA2,Apolipoprotein A-II,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,49258,-0.00209691378300955,0.0121431305623405,-0.0258974496851969,0.0217036221191778,0.862902247352461
APOA2,Apolipoprotein A-II,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,49258,0.0264926178762111,0.0205441977677335,-0.0137740097485466,0.0667592455009689,0.197224386403222
APOA2,Apolipoprotein A-II,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,49258,-0.0296304666970898,0.0121322295104705,-0.0534096365376121,-0.00585129685656756,0.014602841398836
APOA2,Apolipoprotein A-II,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,49258,-0.0170141566701306,0.0171007852057421,-0.0505316956733852,0.016503382333124,0.31978024881649
APOA2,Apolipoprotein A-II,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,49258,0.0162761740447094,0.0209070381976531,-0.0247016208226906,0.0572539689121094,0.43628222435472
APOA2,Apolipoprotein A-II,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,49258,0.0263889058433391,0.00817176953369333,0.0103722375573001,0.042405574129378,0.00124303368343923
APOA2,Apolipoprotein A-II,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37510,0.0559779961940371,0.0199202038549042,0.0169343966384248,0.0950215957496493,0.00496400426748136
APOA2,Apolipoprotein A-II,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37510,0.0599772495320165,0.0170383466953338,0.0265820900091622,0.0933724090548707,0.00043363874483303
APOA2,Apolipoprotein A-II,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37510,0.113808416725416,0.024528329659755,0.0657328905922967,0.161883942858536,3.53950143200856e-06
APOA2,Apolipoprotein A-II,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37510,-0.0135058130691571,0.0190856446614051,-0.0509136766055111,0.0239020504671969,0.479187131727543
APOA2,Apolipoprotein A-II,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49244,-0.0404706383877576,0.0279141343975702,-0.0951823418069953,0.0142410650314801,0.147122682867374
APOA2,Apolipoprotein A-II,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49244,0.0656928409333287,0.0433540007234623,-0.0192810004846574,0.150666682351315,0.129720832453339
APOA2,Apolipoprotein A-II,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49244,0.00385252796969681,0.0662146714627854,-0.125928228097363,0.133633284036756,0.953603925938728
APOA2,Apolipoprotein A-II,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49244,0.15970456582512,0.0704627207860845,0.0215976330843943,0.297811498565846,0.0234306923307314
APOA2,Apolipoprotein A-II,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49244,0.00519203056350567,0.0232260297541076,-0.0403309877545451,0.0507150488815565,0.82311472242975
APOA2,Apolipoprotein A-II,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49244,5.8289150509862e-05,0.0320090715151369,-0.0626794910191585,0.0627960693201782,0.998547055398652
APOA2,Apolipoprotein A-II,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49244,0.0110972311614726,0.016976590469714,-0.0221768861591667,0.044371348482112,0.513326493300849
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35142,0.0271814234415169,0.0230080852373784,-0.0179144236237447,0.0722772705067785,0.237496759190334
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35142,0.0311026583841969,0.0237760803574697,-0.0154984591164437,0.0777037758848375,0.190873288935175
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35142,0.0789150169297944,0.0338167190002727,0.0126342476892599,0.145195786170329,0.0196493219974563
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35142,0.03015804820017,0.0139064646697533,0.00290137744745354,0.0574147189528864,0.0301498966302947
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",39026,0.0425134723725864,0.0111670461319351,0.0206260619539936,0.0644008827911792,0.000141490222500494
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",39026,-0.0398681008662464,0.0131176702247053,-0.0655787345066688,-0.014157467225824,0.00237777919202229
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",39026,-0.00381540819098837,0.0109390520080911,-0.0252559501268469,0.0176251337448701,0.727256070599088
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",39026,0.0439558498932149,0.0250848976829069,-0.00521054956528259,0.0931222493517124,0.0797562586628204
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",39026,0.0370665061348257,0.0140205935584334,0.00958614276029627,0.0645468695093552,0.00821308997977173
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",39026,0.0284396750427821,0.0202386594757229,-0.0112280975296347,0.068107447615199,0.159988844716971
APOA2,Apolipoprotein A-II,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,49258,0.00153681542097678,0.0226991459294127,-0.0429535106006721,0.0460271414426257,0.94602220466084
APOA2,Apolipoprotein A-II,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,49258,0.011014634635072,0.0171789653059674,-0.0226561373646241,0.0446854066347681,0.521419658538433
APOA2,Apolipoprotein A-II,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,49258,0.0581930100802519,0.0459587011292121,-0.0318860441330039,0.148272064293508,0.20545538816385
APOA2,Apolipoprotein A-II,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,49258,0.00504836441206803,0.0161034526588911,-0.0265144027993586,0.0366111316234946,0.753907287026515
APOA2,Apolipoprotein A-II,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,49258,0.00515381096456281,0.0187388673857627,-0.031574369111532,0.0418819910406577,0.783293551135394
APOA2,Apolipoprotein A-II,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),49258,0.0201715801881069,0.0227830768454626,-0.0244832504289997,0.0648264108052135,0.375964701712087
APOA2,Apolipoprotein A-II,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,49258,0.00791516762084363,0.00762752003538134,-0.00703477164850379,0.0228651068901911,0.29941675065404
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34166,0.0888157230999661,0.0202863975500105,0.0490543839019456,0.128577062297987,1.2217910351858e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34166,0.0724594049197054,0.0252156932131556,0.0230366462219205,0.12188216361749,0.00407563602482724
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34166,-0.0629618689723046,0.0174635897298402,-0.0971905048427914,-0.0287332331018177,0.000314821517206919
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34166,-0.0244515066708787,0.0163915984254301,-0.0565790395847218,0.00767602624296435,0.135838689453766
APOA2,Apolipoprotein A-II,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,49337,-0.00861740462513859,0.0101386781203217,-0.0284892137409692,0.011254404490692,0.39536105952249
APOA2,Apolipoprotein A-II,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,49337,0.0622768094389177,0.0286184290611535,0.00618468847905683,0.118368930398779,0.0295587221475499
APOA2,Apolipoprotein A-II,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,49337,0.00506726213390684,0.00850178004823013,-0.0115962267606242,0.0217307510284379,0.551166112335725
APOA2,Apolipoprotein A-II,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,49337,0.0325409347648896,0.00817141032849641,0.0165249705210367,0.0485568990087426,6.8493761330877e-05
APOA2,Apolipoprotein A-II,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,49337,0.0239537781989649,0.0139198271374405,-0.00332908299041846,0.0512366393883482,0.0852954417919033
APOA2,Apolipoprotein A-II,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,49337,0.0046295546695321,0.0104302888483178,-0.0158138114731707,0.025072920812235,0.657150884520703
APOA2,Apolipoprotein A-II,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,49337,0.00239173764176925,0.00852725467667975,-0.0143216815245231,0.0191051568080616,0.779110956104798
APOA2,Apolipoprotein A-II,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,49337,0.0648429762986476,0.0263194480628955,0.0132568580953725,0.116429094501923,0.0137597706215285
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43535,0.00710800369417974,0.00885978464351245,-0.0102571742071047,0.0244731815954642,0.422405891138647
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43535,0.022043119055536,0.00920654550469907,0.00399828986632578,0.0400879482447461,0.0166654402125226
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43535,-0.015939777363314,0.00974974390351982,-0.0350492754142128,0.00316972068758484,0.102093657712712
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43535,-0.00705525887923972,0.0132607405880815,-0.0330463104318794,0.0189357926734,0.594705778589225
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43535,0.000818660233555596,0.00888049672834137,-0.0165871133539935,0.0182244338211047,0.926551301576236
APOA2,Apolipoprotein A-II,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,49147,-0.0188810609519537,0.00890162648143032,-0.0363282488555572,-0.00143387304835032,0.0339273763118444
APOA2,Apolipoprotein A-II,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,49147,-0.0142868723234745,0.00725810705179524,-0.0285127621449932,-6.09825019558634e-05,0.0490356258598341
APOA2,Apolipoprotein A-II,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,49147,-0.0021608312212697,0.00750809729482098,-0.0168767019191188,0.0125550394765794,0.773502742832269
APOA2,Apolipoprotein A-II,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,49147,0.0156109217341578,0.0163489492295706,-0.0164330187558007,0.0476548622241162,0.339661179537146
APOA2,Apolipoprotein A-II,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),49162,-0.0305813006092549,0.00808087160634105,-0.0464198089576833,-0.0147427922608264,0.000154526154412353
APOA2,Apolipoprotein A-II,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,49162,0.0365855954914813,0.0159290631474246,0.00536463172252899,0.0678065592604335,0.0216414729140678
APOA2,Apolipoprotein A-II,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),49258,-0.0145490153980812,0.00736536806612543,-0.0289851368076871,-0.000112893988475403,0.0482446573855475
APOA2,Apolipoprotein A-II,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,49258,-0.00817095811342784,0.00841036186901055,-0.0246552673766885,0.00831335114983284,0.331293810676686
APOA2,Apolipoprotein A-II,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,49258,0.00260989192938861,0.0127482813932486,-0.0223767396013786,0.0275965234601558,0.837789062249537
APOA2,Apolipoprotein A-II,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,49258,-0.00780293553529443,0.0177009872267911,-0.042496870499805,0.0268909994292161,0.659348621252201
APOA2,Apolipoprotein A-II,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,49258,0.0475170217916937,0.0225865576254358,0.00324736884583948,0.0917866747375479,0.0354105437881344
APOA2,Apolipoprotein A-II,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,49258,-0.00557133162058049,0.0208830346555589,-0.0465020795454759,0.0353594163043149,0.789635557277824
APOA2,Apolipoprotein A-II,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40505,-0.0278346827065294,0.00490920255205074,-0.0374567197085488,-0.01821264570451,1.46381709132455e-08
APOA2,Apolipoprotein A-II,Physical activities,X864.Number of days or week walked 10+ minutes,48834,0.00256405826305549,0.02641389854857,-0.0492071828921417,0.0543352994182527,0.922669957766653
APOA2,Apolipoprotein A-II,Physical activities,X874.Duration of walks,46155,0.00512659464969979,0.00400661463213631,-0.00272637002928738,0.012979559328687,0.200727016091364
APOA2,Apolipoprotein A-II,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48008,0.0300741636964775,0.0255843023143821,-0.0200710688397114,0.0802193962326664,0.239812487710208
APOA2,Apolipoprotein A-II,Physical activities,X894.Duration of moderate activity,43772,-0.0265760547538905,0.0316430147268722,-0.08859636361856,0.035444254110779,0.400994416623413
APOA2,Apolipoprotein A-II,Physical activities,X90087.No-wear time bias adjusted average acceleration,32926,-0.0103229557569473,0.00924721413143322,-0.0284474954545564,0.00780158394066187,0.264352162432772
APOA2,Apolipoprotein A-II,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47951,0.0390674975035436,0.0263811967263103,-0.0126396480800245,0.0907746430871117,0.138654235252687
APOA2,Apolipoprotein A-II,Physical activities,X914.Duration of vigorous activity,38992,0.0051930136500274,0.0048928872621314,-0.00439704538375015,0.0147830726838049,0.288561881441059
